[
    {
        "src_smiles": "CCc1nc(CN(C)C2CCN(CCn3cc(C#N)cn3)C2)no1",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule consists of several key fragments: an ethyl-substituted oxadiazole ring (CCc1nc...no1), an N-methyl aminomethyl linker (-CH2N(C)-), a central piperidine ring (-C2CCN...C2), an ethyl linker (-CC-), and a terminal cyano-substituted heterocycle, likely a cyano-pyrazole or similar bicyclic system (n3cc(C#N)cn3). The piperidine nitrogen provides a key basic center.\",\n    \"Property_Analysis\": \"DRD2 receptor activity often requires a basic amine (here, the piperidine nitrogen) for interaction with acidic residues like Asp114 in the binding site, and aromatic/lipophilic groups for occupying hydrophobic pockets and engaging in pi-stacking interactions. The oxadiazole and the cyano-heterocycle serve as these aromatic groups. The overall molecular shape, flexibility, and the distance between the basic nitrogen and aromatic moieties are critical determinants of binding affinity and selectivity.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The terminal cyano-heterocycle (n3cc(C#N)cn3) and the ethyl-oxadiazole head group may not be optimal fragments for strong DRD2 binding compared to established pharmacophores (e.g., substituted phenyl rings, benzamides, arylpiperazines). The specific electronic and steric properties of these groups might lead to suboptimal interactions within the DRD2 binding pocket. The nitrile group could also present metabolic stability issues or unfavorable electronic properties for binding.\",\n    \"Optimization_for_Source_Molecule\": \"To enhance DRD2 activity, the terminal cyano-heterocycle (n3cc(C#N)cn3) will be replaced with a 2,3-dichlorophenyl group. This moiety is present in known potent DRD2 ligands like Aripiprazole and is known to fit well into a specific hydrophobic subpocket of the receptor. This modification aims to improve hydrophobic and potential halogen bonding interactions while retaining the core structure including the essential basic piperidine nitrogen and the ethyl linker.\",\n    \"Final_Target_Molecule\": \"CCc1nc(CN(C)C2CCN(CCc3ccc(Cl)c(Cl)c3)C2)no1\"\n  }\n]"
    },
    {
        "src_smiles": "CC(Cc1c[nH]c2ccccc12)NCC(O)c1cccc(Cl)c1",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule, CC(Cc1c[nH]c2ccccc12)NCC(O)c1cccc(Cl)c1, features a secondary amine linker connecting two main fragments: 1) A 1-(3-indolylmethyl)ethyl group derived from indole and alanine. 2) A 2-hydroxy-2-(meta-chlorophenyl)ethyl group derived from phenylethanolamine.\",\n    \"Property_Analysis\": \"Dopamine D2 receptor (DRD2) ligands often contain an aromatic or heteroaromatic system linked via an alkylamine chain to another moiety, frequently aromatic. The secondary amine is likely protonated at physiological pH, interacting with anionic residues like Asp114 in DRD2. The indole group can participate in pi-stacking or hydrophobic interactions. The meta-chlorophenyl ethanolamine part provides potential hydrogen bonding (OH group) and hydrophobic/halogen interactions (Cl atom).\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The bulky and somewhat flexible 1-(3-indolylmethyl)ethyl group may not be optimal for fitting into the DRD2 binding pocket compared to more canonical DRD2 pharmacophores (e.g., phenethylamines, piperazines/piperidines linked to specific aromatic systems). The overall conformation might be suboptimal, and the specific indole substitution pattern isn't typical for high-affinity DRD2 ligands.\",\n    \"Optimization_for_Source_Molecule\": \"To improve DRD2 affinity, replace the potentially suboptimal 1-(3-indolylmethyl)ethyl moiety with a classic phenethylamine group (PhCH2CH2-), which is a well-established pharmacophore for DRD2 binding. This simplification removes the potentially less favorable indole group and the methyl branch, creating a more linear Ar-ethylamine structure leading to the secondary amine. The other part of the molecule (the secondary amine linked to the 2-hydroxy-2-(meta-chlorophenyl)ethyl group) is retained as it contains features (amine, hydroxyl, chloro-aromatic) often compatible with receptor binding.\",\n    \"Final_Target_Molecule\": \"c1ccc(cc1)CCNCC(O)c2cccc(Cl)c2\"\n  }\n]"
    },
    {
        "src_smiles": "CN1CCCN(CCn2ccc3ccc(C(N)=O)cc32)CC1",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The molecule features an N-methylpyrrolidine ring providing a basic nitrogen center, connected via an ethyl linker (-CH2CH2-) to the nitrogen atom of an azaindole system. The azaindole core is substituted with a carboxamide group (-C(N)=O) on its benzene ring moiety (position 6).\",\n    \"Property_Analysis\": \"The molecule contains recognized pharmacophoric elements for Dopamine D2 Receptor (DRD2) interaction. The protonatable nitrogen in the pyrrolidine ring can form a salt bridge with the conserved Asp114 residue in DRD2. The azaindole-carboxamide portion provides an aromatic system capable of pi-stacking and hydrophobic interactions, along with hydrogen bond donors/acceptors (amide group), potentially interacting with residues in the DRD2 binding pocket. The overall structure suggests potential, likely moderate, affinity for DRD2.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The primary limitation is likely the short ethyl linker connecting the basic amine and the aromatic core. Many potent DRD2 ligands, such as Aripiprazole, utilize longer linkers (e.g., butyl) to achieve optimal positioning of these key pharmacophores within the binding site. The N-methylpyrrolidine moiety might also be suboptimal compared to piperazine or piperidine derivatives frequently found in high-affinity DRD2 ligands. The azaindole core itself might have slightly different electronic and steric properties compared to more common DRD2 scaffolds.\",\n    \"Optimization_for_Source_Molecule\": \"To enhance DRD2 activity, the ethyl linker (-CH2CH2-) was replaced with a longer butyl linker (-CH2CH2CH2CH2-). This modification aims to improve the spatial arrangement and distance between the basic N-methylpyrrolidine nitrogen and the azaindole-carboxamide system, potentially leading to a better fit and stronger interactions within the DRD2 binding pocket, mimicking the linker length observed in potent DRD2 modulators.\",\n    \"Final_Target_Molecule\": \"CN1CCCN(CCCCn2ccc3ccc(C(N)=O)cc32)CC1\"\n  }\n]"
    },
    {
        "src_smiles": "CC(C)(C)C(=O)N1c2ccccc2CCc2ccccc21",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule, N-pivaloyl-10,11-dihydro-5H-dibenz[b,f]azepine (SMILES: CC(C)(C)C(=O)N1c2ccccc2CCc2ccccc21), features a tricyclic dibenzazepine core. The nitrogen atom of the azepine ring is substituted with a bulky, non-basic pivaloyl group (tert-butyl carbonyl).\",\n    \"Property_Analysis\": \"The dibenzazepine scaffold is present in various CNS-active compounds, including some antipsychotics targeting dopamine receptors. However, DRD2 ligands typically possess a basic amine moiety capable of forming ionic interactions with key residues (e.g., Asp114) in the receptor binding site.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The primary limitation for DRD2 activity is the N-pivaloyl substituent. The amide nitrogen is non-basic and sterically hindered by the tert-butyl group, preventing the formation of crucial ionic/hydrogen bond interactions typically required for high-affinity DRD2 binding.\",\n    \"Optimization_for_Source_Molecule\": \"To improve DRD2 activity, the non-basic N-pivaloyl group should be replaced with a substituent containing a basic amine, often separated by a short alkyl linker. A common strategy involves introducing a dialkylaminoethyl group, mimicking pharmacophores found in known DRD2 ligands.\",\n    \"Final_Target_Molecule\": \"CN(C)CCN1c2ccccc2CCc2ccccc21\"\n  }\n]"
    },
    {
        "src_smiles": "CCN(CC)CCNc1n[n+]([O-])c2cc3c(cc2[n+]1[O-])CCC3",
        "prop": "drd",
        "json_results": "[{\n  \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a diethylaminoethylamino side chain (CCN(CC)CCN-) attached to a complex heterocyclic core. This core consists of a furoxan ring ([n+]([O-])c-N=N-[n+]([O-])) fused with a tetrahydroindene system.\",\n  \"Property_Analysis\": \"The diethylaminoethylamino side chain contains a basic tertiary amine, a common feature in many CNS active compounds, including some DRD2 ligands, which can form ionic interactions. The fused ring system provides rigidity and lipophilicity, but the furoxan moiety introduces significant polarity via the N-oxides and has unusual electronic properties.\",\n  \"Limitation_in_Source_Molecule_for_Property\": \"The furoxan ring system is not a typical pharmacophore for high-affinity DRD2 ligands. Its high polarity and specific electronic nature may hinder optimal binding within the typically more hydrophobic DRD2 binding site. The overall structure might not align well with established DRD2 pharmacophore models.\",\n  \"Optimization_for_Source_Molecule\": \"To improve potential DRD2 activity, the non-standard furoxan-tetrahydroindene core is replaced with a scaffold more commonly found in DRD2 ligands. A phenylpiperazine moiety is selected, known for its presence in several DRD2 antagonists/partial agonists. The original diethylaminoethylamino side chain is connected to one nitrogen of the piperazine ring, while the phenyl group (with a chloro substituent for potentially improved binding/lipophilicity) is attached to the other piperazine nitrogen.\",\n  \"Final_Target_Molecule\": \"CCN(CC)CCN1CCN(c2cccc(Cl)c2)CC1\"\n}]"
    },
    {
        "src_smiles": "CCC(=O)N(c1ccc(Cl)c(Cl)c1)C1CCCC1N",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule, CCC(=O)N(c1ccc(Cl)c(Cl)c1)C1CCCC1N, is interpreted as N-(1-aminocyclopentyl)-N-(3,4-dichlorophenyl)propanamide. It features a propanoyl group attached to a tertiary amide nitrogen. This nitrogen is also substituted with a 3,4-dichlorophenyl ring and a 1-aminocyclopentyl group. The key functional groups are: tertiary amide, 3,4-dichlorophenyl ring (lipophilic, electron-withdrawing), and a primary amine on a cyclopentyl ring (basic center).\",\n    \"Property_Analysis\": \"The molecule contains structural elements sometimes found in DRD2 ligands: an aromatic group (dichlorophenyl) and a basic amine center separated by a linker (amide and quaternary carbon). The 3,4-dichloro substitution pattern on the phenyl ring is common in CNS-active compounds. The primary amine provides basicity required for interaction with the acidic residue (e.g., Asp) in the DRD2 binding pocket. However, the overall structure, particularly the N-aryl, N-alkyl tertiary amide linkage and the primary amine, may not be optimal for high-affinity DRD2 binding compared to classical antagonists.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The primary amine (-NH2) is often less potent and metabolically less stable compared to secondary or tertiary amines typically found in high-affinity DRD2 ligands. Primary amines can be readily metabolized (e.g., via deamination). Furthermore, the linker containing the tertiary amide and the quaternary carbon attached to the cyclopentyl ring might impose conformational constraints that hinder optimal positioning of the aromatic ring and the basic amine within the DRD2 binding site. The rigidity and specific geometry might not match the requirements for strong receptor interaction.\",\n    \"Optimization_for_Source_Molecule\": \"To potentially improve DRD2 activity and metabolic stability, the primary amine will be converted to a tertiary amine. Methylation of the primary amine to a dimethylamino group (-N(CH3)2) introduces a tertiary amine, which is a common feature in potent DRD2 ligands, potentially improving binding affinity and reducing metabolic susceptibility compared to the primary amine. This modification maintains the core structure while addressing a key limitation.\",\n    \"Final_Target_Molecule\": \"CCC(=O)N(c1ccc(Cl)c(Cl)c1)C1CCCC1N(C)C\"\n  }\n]"
    },
    {
        "src_smiles": "COc1cc2c(cc1OC)CC(N1CCOCC1)C2",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a 5,6-dimethoxyindane core. A morpholine ring is attached via a methylene bridge to the C1 position of the indane cyclopentane ring. Key features include the electron-rich dimethoxybenzene moiety and the tertiary amine within the morpholine ring.\",\n    \"Property_Analysis\": \"DRD2 (Dopamine D2 Receptor) activity typically requires interaction with key residues in the receptor's binding pocket. Essential interactions often involve a basic nitrogen atom forming a salt bridge with an acidic residue (e.g., Asp114) and aromatic/hydrophobic interactions with other residues within the pocket.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The morpholine nitrogen, while basic, might not possess the optimal pKa or be ideally positioned for the crucial ionic interaction with DRD2's Asp114 residue compared to more common pharmacophores like piperazines or piperidines. The overall shape and substituent pattern of the dimethoxyindane-morpholine combination might lead to suboptimal fit and steric clashes within the DRD2 binding site, limiting affinity.\",\n    \"Optimization_for_Source_Molecule\": \"To enhance DRD2 activity, the morpholine moiety, which might be suboptimal for binding, can be replaced with a piperazine group, specifically an N-methylpiperazine. Piperazines are common scaffolds in DRD2 ligands, offering potentially better positioning and basicity for the key nitrogen interaction. The N-methyl group can also explore a hydrophobic pocket.\",\n    \"Final_Target_Molecule\": \"COc1cc2c(cc1OC)CC(N1CCN(C)CC1)C2\"\n  }\n]"
    },
    {
        "src_smiles": "CN1CC=C(c2c[nH]c3ccc(-c4ccccc4)cc23)CC1",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features an N-methyl-1,2,3,6-tetrahydropyridine ring linked via an exocyclic double bond at its 4-position to the 2-position of an indole derivative. The indole core is substituted at the 6-position with a phenyl group.\",\n    \"Property_Analysis\": \"The molecule contains a basic nitrogen atom (in the tetrahydropyridine ring), a common feature for DRD2 ligands interacting with Asp114. The indole and phenyl groups provide lipophilic character, potentially interacting with hydrophobic pockets within the DRD2 receptor. The overall structure resembles scaffolds found in some CNS agents.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The exocyclic double bond linking the tetrahydropyridine and indole rings introduces rigidity and planarity, which might limit optimal conformational adaptation to the DRD2 binding site compared to a more flexible single bond linker. The unsubstituted phenyl ring might lack specific interactions or favorable physicochemical properties for potent binding.\",\n    \"Optimization_for_Source_Molecule\": \"To enhance flexibility and potentially improve binding pose, the exocyclic double bond can be reduced to a single bond, converting the tetrahydropyridine to a piperidine ring directly attached to the indole. To potentially increase potency or modify pharmacokinetic properties, the phenyl ring can be substituted, for example, with a fluorine atom, a common modification in CNS drug design (e.g., para-fluoro substitution).\",\n    \"Final_Target_Molecule\": \"CN1CCC(c2c[nH]c3ccc(-c4ccc(F)cc4)cc23)CC1\"\n  }\n]"
    },
    {
        "src_smiles": "CON=C(CCN1CCN(c2ccccn2)CC1)c1ccccc1",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a central carbon atom linked to a methoxyimine group (CON=C), a phenyl ring (c1ccccc1), and an ethylpiperazine moiety (CCN1CCN(...)CC1). The distal nitrogen of the piperazine is substituted with a 2-pyridinyl group (c2ccccn2). Key components are the phenyl ring, the pyridinylpiperazine group, and the linking chain incorporating a methoxyimine.\",\n    \"Property_Analysis\": \"The pyridinylpiperazine motif is common in DRD2 ligands, often acting as a pharmacophore interacting with the receptor. The phenyl ring can contribute to binding through hydrophobic interactions. The overall structure suggests potential affinity for DRD2, typical of arylpiperazine derivatives. The distance and relative orientation between the aromatic systems and the basic nitrogen are crucial for receptor interaction.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The methoxyimine group (CON=C) is the primary structural feature likely limiting optimal DRD2 activity. This group is not a typical pharmacophore element in high-affinity DRD2 ligands and may introduce unfavorable steric bulk, electronic properties, or conformational constraints compared to more established linkers or functional groups (e.g., amides, ketones, simple alkyl chains) found in known DRD2 antagonists/agonists. It might also pose metabolic stability issues.\",\n    \"Optimization_for_Source_Molecule\": \"To potentially enhance DRD2 activity, the methoxyimine group will be replaced with a carbonyl group (C=O). This converts the core structure adjacent to the phenyl ring into a ketone. Ketones, particularly in butyrophenone-like structures (though this is slightly different), are known motifs in DRD2 ligands (e.g., Haloperidol contains a ketone). This change maintains the key pharmacophoric elements (phenyl, basic amine, linker) while replacing the unusual methoxyimine with a group more commonly associated with DRD2 binding, potentially improving binding interactions (e.g., hydrogen bonding) and optimizing physicochemical properties.\",\n    \"Final_Target_Molecule\": \"O=C(CCN1CCN(c2ccccn2)CC1)c1ccccc1\"\n  }\n]"
    },
    {
        "src_smiles": "O=C1CC(CN2CCN(Cc3ccccc3)CC2)Oc2ccccc21",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a benzoxepinone core fused with a phenyl ring. A methylene linker connects this core to a piperazine ring. The distal nitrogen of the piperazine is substituted with a benzyl group.\",\n    \"Property_Analysis\": \"The molecule contains a basic piperazine nitrogen, a common feature in CNS ligands, potentially interacting with acidic residues like Asp114 in the DRD2 receptor binding site. The overall structure possesses lipophilic regions (benzoxepinone, benzyl group) and a polar core (piperazine, ketone, ether), suggesting potential membrane permeability and receptor interaction capabilities. The structural elements resemble portions of known CNS-active compounds.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The N-benzyl substituent on the piperazine is relatively non-specific and may not provide optimal interactions within the DRD2 binding pocket compared to established pharmacophores. The benzoxepinone moiety might not be the most favorable scaffold for high DRD2 affinity or selectivity. The overall flexibility could lead to non-optimal binding conformations.\",\n    \"Optimization_for_Source_Molecule\": \"To enhance DRD2 activity, the N-benzyl group on the piperazine will be replaced with a 2,3-dichlorophenyl group. Arylpiperazines, particularly those with specific chlorine substitution patterns on the phenyl ring, are known motifs in potent DRD2 ligands (e.g., Aripiprazole, Cariprazine). This modification introduces specific electronic and steric properties expected to improve binding affinity and potentially selectivity for DRD2.\",\n    \"Final_Target_Molecule\": \"O=C1CC(CN2CCN(c3cccc(Cl)c3Cl)CC2)Oc2ccccc21\"\n  }\n]"
    },
    {
        "src_smiles": "COc1ccccc1NC(=O)CN1CCN(Cc2ccccc2)CC1",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a methoxy-substituted aniline core linked via an acetamide group to a piperazine ring, which is further N-substituted with a benzyl group. Key features include: 1) Anisidine moiety (potential aromatic interactions, H-bond donor/acceptor). 2) Amide linker (H-bond donor/acceptor, conformational influence). 3) Piperazine core (common CNS scaffold, contains basic nitrogen). 4) N-Benzyl group (lipophilic aromatic substituent).\",\n    \"Property_Analysis\": \"The molecule contains structural elements often found in CNS-active compounds, particularly ligands targeting aminergic GPCRs like dopamine receptors. The piperazine nitrogen is likely protonated under physiological pH and can form ionic interactions with acidic residues (e.g., Aspartic acid) in the DRD2 binding site. The aromatic rings can engage in pi-stacking or hydrophobic interactions within the receptor pocket. The overall structure suggests potential, but likely non-optimal, interaction with DRD2.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The N-benzyl group on the piperazine is relatively simple and lacks features often seen in potent DRD2 ligands, such as specific halogen substitutions or extended aromatic systems known to enhance affinity and selectivity. The methoxy group on the terminal phenyl ring might not be optimally positioned or suitable for strong interactions compared to other substituents. The overall combination and spatial arrangement of these groups may not perfectly fit the DRD2 binding pocket for high-affinity binding.\",\n    \"Optimization_for_Source_Molecule\": \"To enhance DRD2 activity, a common strategy is to modify the N-aryl substituent on the piperazine ring, as this region often interacts significantly with the receptor's hydrophobic pockets. Replacing the simple benzyl group with a dichlorophenyl group, specifically 2,3-dichlorophenyl, is a well-established modification found in several potent DRD2 ligands (e.g., aripiprazole analog precursors). This substitution pattern is known to increase binding affinity by providing more specific hydrophobic and potential halogen-bonding interactions within the DRD2 binding site.\",\n    \"Final_Target_Molecule\": \"COc1ccccc1NC(=O)CN1CCN(c2cccc(Cl)c2Cl)CC1\"\n  }\n]"
    },
    {
        "src_smiles": "CCC(=O)NCCCCN1CCN(c2ccccc2OC)CC1",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a propionamide group connected via a butyl linker to a piperazine ring, which is further N-substituted with an ortho-methoxyphenyl group. Key components are: 1) Propionamide head group, 2) Butyl linker, 3) Piperazine core (basic nitrogens), 4) o-Methoxyphenyl tail group.\",\n    \"Property_Analysis\": \"Arylpiperazine moieties are common scaffolds for DRD2 ligands. The distal basic nitrogen of the piperazine is crucial for interacting with Asp114 in DRD2. The aryl group explores a hydrophobic pocket, and its substituents significantly influence affinity and selectivity. The linker length modulates the positioning of the pharmacophoric elements. The terminal amide group contributes to overall physicochemical properties and might have minor receptor interactions.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The o-methoxyphenyl group, while present in some ligands, might not be optimal for DRD2 affinity compared to other substitution patterns (e.g., dichlorophenyl groups found in potent antagonists). The simple propionamide group might lack specific interactions or optimal size/shape compared to more complex terminal moieties often seen in high-affinity DRD2 ligands.\",\n    \"Optimization_for_Source_Molecule\": \"Replace the o-methoxyphenyl group with a 2,3-dichlorophenyl group. This substitution is frequently observed in potent DRD2 antagonists (e.g., aripiprazole derivatives) and is known to enhance binding affinity by optimizing interactions within the hydrophobic pocket of the receptor.\",\n    \"Final_Target_Molecule\": \"CCC(=O)NCCCCN1CCN(c2ccc(Cl)c(Cl)c2)CC1\"\n  }\n]"
    },
    {
        "src_smiles": "N#CCCNCCCN1CCCCC1",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule, N#CCCNCCN1CCCCC1, features a terminal nitrile group (N#C), a propyl linker (CCC), a secondary amine (NH), an ethyl linker (CC), and a piperidine ring containing a tertiary amine.\",\n    \"Property_Analysis\": \"The molecule contains two basic amine centers (secondary amine and piperidine nitrogen), which are common features in DRD2 ligands potentially interacting with acidic residues (e.g., Asp114). The piperidine ring provides some lipophilicity. The nitrile offers a potential hydrogen bond acceptor site.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The primary limitation for DRD2 activity is the absence of an aromatic or heteroaromatic ring system, often crucial for pi-stacking and hydrophobic interactions within the receptor's binding pocket. The flexible aliphatic linker (CCCNCC) can lead to an unfavorable entropy change upon binding. The nitrile group, while polar, is not a typical pharmacophore element associated with high-affinity DRD2 ligands compared to other functional groups or aromatic systems.\",\n    \"Optimization_for_Source_Molecule\": \"Optimization involves replacing the terminal nitrile group with a 4-fluorophenyl group. This introduces an aromatic moiety, a key feature in many potent DRD2 ligands (e.g., antipsychotics like haloperidol). The 4-fluoro substitution is often beneficial for CNS penetration and binding affinity. This modification retains the essential basic amine pharmacophores (secondary amine and piperidine) and the linker length, aiming to establish favorable interactions within the DRD2 binding site.\",\n    \"Final_Target_Molecule\": \"c1cc(F)ccc1CCCNCCN1CCCCC1\"\n  }\n]"
    },
    {
        "src_smiles": "CCN1CCN(c2cccc(Cl)c2)CC1",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule, CCN1CCN(c2cccc(Cl)c2)CC1 (1-(3-chlorophenyl)-4-ethylpiperazine), features a central piperazine ring. One nitrogen is substituted with an ethyl group, and the other nitrogen is substituted with a meta-chlorophenyl group.\",\n    \"Property_Analysis\": \"Arylpiperazines are a well-known scaffold for targeting CNS receptors, including dopamine receptors like DRD2. The specific substitution pattern (meta-chloro on the phenyl ring and ethyl on the distal nitrogen) influences affinity and selectivity for DRD2. Existing data on similar analogs suggests moderate affinity but potential for optimization.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The N-ethyl group is relatively small and lacks specific interactions often found in potent DRD2 ligands, which commonly feature longer, functionalized N-substituents that can interact with accessory binding pockets. The simple meta-chlorophenyl group might offer limited potency and selectivity compared to more elaborate aryl or heteroaryl systems.\",\n    \"Optimization_for_Source_Molecule\": \"To improve DRD2 activity, the N-ethyl group will be replaced with a longer butyl linker attached to a benzisothiazole moiety. This N-arylalkylpiperazine motif is common in potent DRD2 antagonists (e.g., Ziprasidone). The benzisothiazole group can engage in favorable interactions within the DRD2 binding site, and the butyl linker provides optimal spacing.\",\n    \"Final_Target_Molecule\": \"Clc1cccc(N2CCN(CCCCc3snc4ccccc34)CC2)c1\"\n  }\n]"
    },
    {
        "src_smiles": "O=C(CCc1ccc2c(ccn2S(=O)(=O)c2ccccc2)c1)NO",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a 1-(phenylsulfonyl)-1H-pyrrolo[3,2-b]pyridine core substituted at the 5-position with a propionyl hydroxamic acid group [-CH2CH2C(=O)NO]. Key components include the fused heterocyclic core, the flexible propyl linker, the hydroxamic acid moiety, and the phenylsulfonyl group on the pyrrole nitrogen.\",\n    \"Property_Analysis\": \"Dopamine D2 receptor (DRD2) ligands typically possess a basic nitrogen atom capable of forming a salt bridge with Asp114 in the binding site, along with appropriate hydrophobic groups fitting into receptor pockets. The source molecule lacks a strongly basic amine center commonly associated with high DRD2 affinity. The hydroxamic acid group is more characteristic of histone deacetylase (HDAC) inhibitors and might not contribute positively or specifically to DRD2 binding.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The primary limitation for DRD2 activity is the absence of a required basic amine pharmacophore feature. The pyrrole nitrogen is non-basic due to sulfonylation, and the pyridine nitrogen's basicity is moderate and sterically embedded. The terminal hydroxamic acid group is not a typical DRD2 binding motif and may lead to poor selectivity, metabolic instability, or off-target effects (e.g., HDAC inhibition).\",\n    \"Optimization_for_Source_Molecule\": \"To improve DRD2 activity, replace the terminal hydroxamic acid group [-C(=O)NO] with a moiety containing a basic amine center. A common strategy for DRD2 ligands is to introduce a tertiary amine or a piperazine/piperidine ring at the end of an appropriate linker. Replacing the propionyl hydroxamic acid chain [-CH2CH2C(=O)NO] with a N,N-dimethylaminopropyl chain [-CH2CH2CH2N(C)C] introduces a basic nitrogen at a potentially favorable distance from the aromatic core.\",\n    \"Final_Target_Molecule\": \"CN(C)CCCc1ccc2c(ccn2S(=O)(=O)c3ccccc3)c1\"\n  }\n]"
    },
    {
        "src_smiles": "Brc1ccc(OCC2CCN(CC3CC3)CC2)cc1",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule consists of a 4-bromophenoxy group linked via a methylene ether (-OCH2-) to the 4-position of a piperidine ring. The piperidine nitrogen is substituted with a cyclopropylmethyl group.\",\n    \"Property_Analysis\": \"Dopamine D2 receptor ligands often contain an aromatic moiety linked by a spacer (like the ether here) to a basic nitrogen center (the piperidine nitrogen). The basic nitrogen typically forms a salt bridge with Asp114 in the DRD2 binding site. The aromatic group and the N-substituent occupy hydrophobic pockets.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The 4-bromo substituent on the phenyl ring might not be optimal for hydrophobic interactions or could introduce metabolic liabilities compared to other substituents often found in potent DRD2 ligands (e.g., methoxy, chloro, or part of a larger fused system). The N-cyclopropylmethyl group is relatively small and may not optimally fill the N-substituent binding pocket compared to larger alkyl or arylalkyl groups (like n-butyl or phenethyl) commonly seen in high-affinity DRD2 ligands.\",\n    \"Optimization_for_Source_Molecule\": \"To potentially improve DRD2 activity, the 4-bromo group can be replaced with a 4-methoxy group, which is common in potent DRD2 antagonists and provides favorable electronic and steric properties. Additionally, the N-cyclopropylmethyl group can be replaced with an n-butyl group, a substituent found in potent butyrophenone-class DRD2 antagonists like haloperidol, to potentially achieve better occupancy of the N-substituent pocket.\",\n    \"Final_Target_Molecule\": \"COc1ccc(OCC2CCN(CCCC)CC2)cc1\"\n  }\n]"
    },
    {
        "src_smiles": "CCCc1c(C(=O)Nc2cc(O)ccc2C)cnn1-c1ccccc1",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a central pyrazole ring. Substituents include a butyl group at C4, an N-phenyl group at N1, and an amide group at C5. The amide links the pyrazole to a 2-methyl-5-hydroxyphenyl group.\",\n    \"Property_Analysis\": \"DRD2 receptor ligands typically require a basic amine group capable of forming a salt bridge with an aspartate residue (Asp114 in human DRD2) in the binding site, along with specific hydrophobic and aromatic interactions. The spatial arrangement of these features is crucial.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The primary limitation of the source molecule for DRD2 activity is the complete absence of a basic amine group, which is a critical pharmacophoric feature for most potent DRD2 ligands. The overall structure may also lack the optimal shape and electrostatic profile for binding.\",\n    \"Optimization_for_Source_Molecule\": \"Introduce a basic amine group. A common strategy for DRD2 ligands is incorporating a piperazine or a related cyclic amine, or a simple alkylamine. Replacing the non-polar butyl group with an aminoalkyl chain, such as a 3-(diethylamino)propyl group, introduces the necessary basic nitrogen while maintaining some lipophilicity and potentially positioning the amine correctly relative to the aromatic systems.\",\n    \"Final_Target_Molecule\": \"CCN(CC)CCc1c(C(=O)Nc2cc(O)ccc2C)cnn1-c1ccccc1\"\n  }\n]"
    },
    {
        "src_smiles": "CN(C)CCc1c[nH]c2ccc(-n3cnnc3)cc12",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule, CN(C)CCc1c[nH]c2ccc(-n3cnnc3)cc12, features an indole core. A dimethylaminoethyl side chain, a common pharmacophore element for CNS targets, is attached at the C3 position. The C5 position of the indole is substituted with a phenyl ring which is further substituted with a 1,2,4-triazol-1-yl group.\",\n    \"Property_Analysis\": \"DRD2 activity often requires a basic amine (present as dimethylamino) separated by a 2-carbon linker from an aromatic system (indole). This mimics the structure of dopamine. The substituents on the aromatic core modulate binding affinity, selectivity, and pharmacokinetic properties. The 5-substituent (-phenyl-triazole) significantly influences the interaction profile.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The bulky and relatively polar 5-(4-(1,2,4-triazol-1-yl)phenyl) substituent might not be optimal for fitting into the specific lipophilic pockets often found in the DRD2 binding site. Its size and electronic properties may hinder optimal binding affinity or introduce unfavorable interactions compared to established DRD2 ligands.\",\n    \"Optimization_for_Source_Molecule\": \"To potentially improve DRD2 binding, the complex 5-substituent can be replaced with a simpler, smaller, and potentially more lipophilic group known to be favorable in DRD2 ligands. Replacing the 4-(1,2,4-triazol-1-yl)phenyl group with a simple halogen, like Chlorine (Cl), at the 5-position can enhance lipophilicity and potentially improve hydrophobic interactions within the receptor binding site, a common strategy in DRD2 modulator design.\",\n    \"Final_Target_Molecule\": \"CN(C)CCc1c[nH]c2ccc(Cl)cc12\"\n  }\n]"
    },
    {
        "src_smiles": "O=C(O)C(O)Cc1c[nH]c2ccc(O)cc12",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule, O=C(O)C(O)Cc1c[nH]c2ccc(O)cc12 (5-Hydroxyindole-3-glyoxylic acid), features a 5-hydroxyindole core structure. Attached to the 3-position of the indole ring is a glyoxylic acid side chain (-CH(OH)COOH), containing a secondary alcohol and a carboxylic acid functional group. Key features include the indole nitrogen, a phenolic hydroxyl group at the 5-position, an alcoholic hydroxyl, and a carboxylic acid group.\",\n    \"Property_Analysis\": \"Dopamine D2 Receptor (DRD2) ligands typically possess key pharmacophoric features, including a basic nitrogen atom (usually a secondary or tertiary amine) capable of protonation at physiological pH, an aromatic system, and a specific spatial arrangement between these elements. Lipophilicity also plays a role in receptor binding and potentially CNS penetration.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The source molecule lacks a strongly basic amine group characteristic of many DRD2 ligands; the indole nitrogen is only weakly basic. The side chain (-CH(OH)COOH) is highly polar due to the two hydroxyl groups and the carboxylic acid, which likely hinders optimal interaction with the potentially less polar DRD2 binding site and may limit membrane permeability. The overall structure does not strongly align with established DRD2 pharmacophore models.\",\n    \"Optimization_for_Source_Molecule\": \"To enhance DRD2 activity, the primary optimization strategy is to introduce a basic amine group and modify the side chain. Replace the polar glyoxylic acid moiety with a less polar linker incorporating a basic amine, such as N-methylpiperazine, connected via an appropriate spacer (e.g., an ethyl linker) to the indole 3-position. This modification introduces the required basic center and adjusts the polarity and spatial properties to better fit the DRD2 pharmacophore.\",\n    \"Final_Target_Molecule\": \"CN1CCN(CCc2c[nH]c3ccc(O)cc23)CC1\"\n  }\n]"
    },
    {
        "src_smiles": "O=C(O)CCCC1C2CCCN3CCCC(CN1CCO)C23",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule, O=C(O)CCCC1C2CCCN3CCCC(CN1CCO)C23, features a complex polycyclic bridged amine core structure containing multiple nitrogen atoms. Attached to this core are two substituents: a pentanoic acid chain linked to one of the bridgehead carbons (C1) and an N-ethanol group attached to one of the nitrogen atoms (N1). The core contains tertiary amines (N1, N3) which are basic.\",\n    \"Property_Analysis\": \"Dopamine D2 Receptor (DRD2) activity is often associated with molecules containing a basic amine center capable of interacting with Asp114 in the receptor binding site, and typically one or more aromatic/lipophilic groups that occupy hydrophobic pockets. The spatial arrangement and distance between the basic amine and the aromatic features are crucial for high affinity binding.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The source molecule lacks a significant aromatic moiety typically required for strong interaction with hydrophobic pockets in the DRD2 receptor. While it possesses basic nitrogens, their positioning relative to other potential binding features within the complex polycyclic core might not be optimal. The presence of a polar carboxylic acid group is generally unfavorable for CNS penetration (where DRD2 is located) and may introduce undesired polarity or interactions, potentially reducing affinity or bioavailability.\",\n    \"Optimization_for_Source_Molecule\": \"To enhance DRD2 activity, two main modifications are proposed: 1. Removal of the carboxylic acid group and its associated alkyl chain to reduce polarity and potential unfavorable interactions, replacing it with a simple hydrogen atom on the core. 2. Introduction of a pharmacophore element known to favor DRD2 binding. The N-ethanol group (CCO) on nitrogen N1 will be replaced with a 2-(4-fluorophenyl)ethyl group (-CCc1ccc(F)cc1). This introduces a fluoro-substituted aromatic ring connected via a two-carbon linker to the basic nitrogen (N1), a common motif in DRD2 ligands, aiming to establish favorable hydrophobic and potential halogen-bond interactions within the receptor binding site.\",\n    \"Final_Target_Molecule\": \"FC(C=C1)=CC=C1CCN2CC3C4CCCN5CCCC(C35)C42\"\n  }\n]"
    },
    {
        "src_smiles": "CCOc1ccccc1-c1nc(CN2CCN(C)CC2)co1",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule, CCOc1ccccc1-c1nc(CN2CCN(C)CC2)co1, features several key structural elements: an ethoxy group (-OEt) attached to a phenyl ring, a 1,3,4-oxadiazole ring acting as a linker between the phenyl ring and a methylene group, and an N-methylpiperazine moiety connected via the methylene linker.\",\n    \"Property_Analysis\": \"The N-methylpiperazine group contains a basic tertiary amine, which is a common pharmacophore for interacting with aminergic GPCRs like the Dopamine D2 Receptor (DRD2). This nitrogen is likely protonated under physiological conditions and forms a salt bridge with acidic residues (e.g., Asp114) in the DRD2 binding site. The aromatic phenyl ring and the ethoxy group contribute to hydrophobic interactions and potentially pi-stacking. The oxadiazole linker influences the overall conformation and spacing between the aromatic moiety and the basic amine.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"While possessing key features for DRD2 binding, the specific combination might not be optimal. The N-methyl group on the piperazine might be too small or not ideally positioned for optimal hydrophobic interactions within the receptor subpocket near the basic amine binding site. The rigidity and electronic properties of the oxadiazole linker might also constrain the molecule into a suboptimal conformation for high-affinity binding.\",\n    \"Optimization_for_Source_Molecule\": \"To potentially improve DRD2 activity, we can modify the substituent on the distal nitrogen of the piperazine ring. Replacing the N-methyl group with a slightly larger N-ethyl group can potentially enhance hydrophobic interactions within the receptor pocket without significantly altering the crucial basicity required for the salt bridge interaction. This is a common optimization strategy for piperazine-containing DRD2 ligands.\",\n    \"Final_Target_Molecule\": \"CCOc1ccccc1-c1nc(CN2CCN(CC)CC2)co1\"\n  }\n]"
    },
    {
        "src_smiles": "CN1CCc2cccc3c2C1Cc1cccc(O)c1-3",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule, CN1CCc2cccc3c2C1Cc1cccc(O)c1-3, features a complex, rigid polycyclic bridged structure. It contains a tetrahydroisoquinoline-like moiety fused within this system. Key functional groups include a tertiary amine (N-methyl) and a phenolic hydroxyl group embedded in an aromatic ring.\",\n    \"Property_Analysis\": \"Dopamine D2 Receptor (DRD2) activity often correlates with the presence of a basic amine and an appropriately positioned aromatic/phenolic group, mimicking dopamine. The rigid structure locks the molecule into a specific conformation, which can influence receptor binding. The source molecule resembles apomorphine derivatives, known DRD2 agonists.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"While possessing the necessary pharmacophoric elements (amine, phenol), the N-methyl group on the tertiary amine is often suboptimal for potent DRD2 agonism compared to larger alkyl groups like N-propyl, which is frequently found in potent agonists like N-propylnorapomorphine (NPA). The rigid conformation might also impose constraints not perfectly matching the DRD2 binding site.\",\n    \"Optimization_for_Source_Molecule\": \"To potentially enhance DRD2 activity, the N-methyl group will be replaced with an N-propyl group. This modification is a common optimization strategy in apomorphine-like DRD2 agonists, often leading to increased affinity and/or efficacy.\",\n    \"Final_Target_Molecule\": \"CCCN1CCc2cccc3c2C1Cc1cccc(O)c1-3\"\n  }\n]"
    },
    {
        "src_smiles": "CC(=O)N1N=C(c2cc(F)ccc2F)CC1c1ccccc1",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule, CC(=O)N1N=C(c2cc(F)ccc2F)CC1c1ccccc1, features a central pyrazoline ring. Key substituents include an N-acetyl group on one pyrazoline nitrogen, a 2,4-difluorophenyl group attached to the imine carbon (C=N) of the pyrazoline, and a phenyl group attached to the saturated carbon (C4) of the pyrazoline ring.\",\n    \"Property_Analysis\": \"Dopamine D2 Receptor (DRD2) ligands typically possess key pharmacophoric features for binding. These often include one or two aromatic rings for hydrophobic and pi-stacking interactions, and a basic nitrogen atom (usually a secondary or tertiary amine) that is protonated at physiological pH to form a salt bridge with an acidic residue (like Asp114) in the receptor binding site. The source molecule has two aromatic rings (difluorophenyl and phenyl) but lacks a strongly basic nitrogen center.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The primary limitation for potential DRD2 activity is the absence of a readily protonatable basic nitrogen atom. The pyrazoline nitrogens are part of an amide (N-acetyl) or an imine system, significantly reducing their basicity. The N-acetyl group might also introduce unfavorable steric or electronic interactions within the DRD2 binding pocket.\",\n    \"Optimization_for_Source_Molecule\": \"To enhance DRD2 activity, a basic nitrogen center needs to be introduced. A rational optimization strategy involves replacing a non-essential, non-basic group with a moiety containing a basic amine, such as piperidine or piperazine, known to be favorable for DRD2 binding. Replacing the C4-phenyl group with a piperidine ring introduces a basic tertiary/secondary amine while maintaining the core pyrazoline structure and the difluorophenyl group.\",\n    \"Final_Target_Molecule\": \"CC(=O)N1N=C(c2cc(F)ccc2F)CC1C1CCNCC1\"\n  }\n]"
    },
    {
        "src_smiles": "NCCCCc1c[nH]c2ccc(F)cc12",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule, NCCCCNc1c[nH]c2ccc(F)cc12 (N-butyl-6-fluoro-1H-carbazol-4-amine), features a planar carbazole core, known to interact with aromatic residues in binding pockets. A fluorine atom is present on the benzene ring (position 6), potentially enhancing metabolic stability or modulating electronic properties. A secondary amine acts as a basic center, likely crucial for salt bridge formation (e.g., with Aspartic acid in DRD2). This amine is attached to a flexible n-butyl chain.\",\n    \"Property_Analysis\": \"The carbazole scaffold combined with a basic amine linked by a chain is a common motif in DRD2 ligands. The basic amine is essential for receptor interaction (Asp114 in DRD2). The n-butyl chain contributes to lipophilicity, influencing solubility, permeability, and potentially hydrophobic interactions within the binding site. The fluorine atom can increase binding affinity through polar interactions or improve pharmacokinetic properties.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The primary limitation is the high flexibility of the n-butyl chain attached to the amine. This conformational freedom can lead to an entropic penalty upon binding and may not ensure optimal positioning of the amine or the hydrophobic chain within the DRD2 binding pocket. The simple alkyl chain lacks specific interactions beyond general hydrophobicity, potentially limiting potency and selectivity.\",\n    \"Optimization_for_Source_Molecule\": \"To improve DRD2 activity, the flexible n-butyl chain should be replaced with a moiety that introduces conformational constraint and potentially more specific interactions. A common strategy for DRD2 ligands is incorporating a piperazine ring, often linked via an ethylene bridge. The piperazine introduces rigidity and allows for substitution on the distal nitrogen to fine-tune properties. Adding a methyl group to the distal piperazine nitrogen (N-methylpiperazine) is a frequent modification known to enhance potency or modulate activity profile in DRD2 ligands.\",\n    \"Final_Target_Molecule\": \"CN1CCN(CCNc2c[nH]c3ccc(F)cc23)CC1\"\n  }\n]"
    },
    {
        "src_smiles": "O=C(NC1CCNCC1)c1ccc2ccccc2c1",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule, N-(piperidin-4-yl)naphthalene-2-carboxamide, consists of a naphthalene ring system linked via an amide bond to the nitrogen atom of a piperidine ring.\",\n    \"Property_Analysis\": \"DRD2 activity often requires a basic nitrogen atom (present in the piperidine ring) capable of protonation and forming ionic interactions, and a lipophilic aromatic moiety (the naphthalene group) interacting with hydrophobic pockets in the receptor. The distance and orientation between these groups, mediated by the amide linker, are crucial.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The naphthalene group, while lipophilic, might not have the optimal size, shape, or electronic properties for strong binding within the DRD2 binding site compared to other aromatic systems frequently found in potent DRD2 ligands. The specific linkage point (naphthalene-2-carboxamide) might also suboptimal.\",\n    \"Optimization_for_Source_Molecule\": \"Replace the naphthalene group with a different aromatic system known to confer good DRD2 activity, such as a substituted phenyl ring. For instance, replacing naphthalene with a 4-fluorophenyl group is a common strategy in DRD2 ligand design, potentially improving binding affinity and pharmacokinetic properties. The core piperidine-amide structure is retained.\",\n    \"Final_Target_Molecule\": \"O=C(NC1CCNCC1)c1ccc(F)cc1\"\n  }\n]"
    },
    {
        "src_smiles": "CC1C2Cc3ccc(O)cc3C1(C)CCN2CC(=O)O",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule possesses a morphinan-like tetracyclic core structure. Key features include a phenolic hydroxyl group on the aromatic ring, a tertiary amine within a piperidine ring, a quaternary carbon, and an N-carboxymethyl substituent.\",\n    \"Property_Analysis\": \"The morphinan scaffold, while primarily associated with opioid receptors, can interact with other CNS targets. The tertiary amine is a key pharmacophoric element for GPCR interaction, potentially forming ionic bonds. The phenolic hydroxyl can participate in hydrogen bonding. The N-substituent significantly modulates activity and selectivity.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The N-carboxymethyl group (-CH2COOH) is highly polar and likely negatively charged at physiological pH. This is generally unfavorable for DRD2 receptor binding, where N-alkyl or N-aralkyl groups, contributing to lipophilicity and specific hydrophobic interactions, are often preferred. The high polarity may also limit BBB penetration and receptor affinity/selectivity.\",\n    \"Optimization_for_Source_Molecule\": \"Replace the N-carboxymethyl group with a substituent known to enhance DRD2 affinity. An N-propyl group is a common feature in dopamine agonists and is expected to improve lipophilicity and fit within the DRD2 binding site compared to the carboxymethyl group. This modification removes the potentially unfavorable negative charge and introduces a hydrophobic chain.\",\n    \"Final_Target_Molecule\": \"CC1C2Cc3ccc(O)cc3C1(C)CCN2CCC\"\n  }\n]"
    },
    {
        "src_smiles": "c1cncc(NC2c3ccccc3OCc3ncccc32)c1",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule, c1cncc(NC2c3ccccc3OCc3ncccc32)c1, features a pyridine ring connected via a secondary amine linker (-NH-) to a complex tricyclic system. This tricyclic core appears to be a derivative of dibenzo[b,f][1,4]oxazepine where one benzene ring is replaced by a pyridine ring, specifically a dihydro derivative based on the 'C2' atom designation suggesting sp3 carbons in the 7-membered ring.\",\n    \"Property_Analysis\": \"The molecule contains structural elements common in CNS-active compounds, including heteroaromatic rings (pyridine) and a secondary amine, which can be protonated. The tricyclic core resembles scaffolds found in some antipsychotic drugs known to interact with DRD2. The nitrogen atoms (pyridine rings, amine linker) could potentially interact with the DRD2 binding site.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The specific conformation, size, and electronic properties of the tricyclic dibenzo-pyridoxazepine core might not be optimal for high-affinity binding to the DRD2 receptor. The oxygen atom in the 7-membered ring might be less favorable than a nitrogen atom found in potent DRD2 ligands like clozapine (diazepine). The exact substitution pattern and the overall topology might lead to steric clashes or suboptimal interactions within the DRD2 binding pocket.\",\n    \"Optimization_for_Source_Molecule\": \"To potentially improve DRD2 activity, the oxygen atom within the 7-membered ring of the tricyclic core can be replaced with a nitrogen atom, mimicking the diazepine core of clozapine. Furthermore, alkylating this new nitrogen (e.g., with a methyl group) is a common strategy in DRD2 ligand optimization to modulate basicity, lipophilicity, and binding interactions. This modification transforms the oxazepine core into a diazepine core.\",\n    \"Final_Target_Molecule\": \"CN1c2ncccc2C(Nc2cnccc2)Cc2ccccc21\"\n  }\n]"
    },
    {
        "src_smiles": "OC(CN1C2CCC1CC(c1ccccc1)C2)c1ccccc1",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule SMILES `OC(CN1C2CCC1CC(c1ccccc1)C2)c1ccccc1` appears to represent a complex structure containing a diphenylmethanol group attached via a methylene linker to a nitrogen atom (N1). This nitrogen is part of a substituted bicyclic system (potentially a phenyl-substituted tropane derivative `C2CCC1CC(c1ccccc1)C2`). Key features include the basic nitrogen (N1), a hydroxyl group, two phenyl rings, and a potentially strained/complex bicyclic amine scaffold.\",\n    \"Property_Analysis\": \"The molecule possesses features common to GPCR ligands: a basic amine for potential ionic interactions (e.g., with Aspartic acid in DRD2) and hydrophobic aromatic groups. However, the specific arrangement, bulkiness of the diphenylmethanol group, the short linker (-CH2-), and the potentially complex bicyclic scaffold may not be optimal for potent and selective DRD2 binding. Related structures like Benztropine show some DRD2 affinity but are more potent at other receptors (e.g., muscarinic).\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The diphenylmethanol moiety lacks substituents known to enhance DRD2 affinity (e.g., halogens). The single methylene linker (-CH2-) between the basic nitrogen and the bulky aromatic group is likely suboptimal in length and flexibility compared to typical linkers (e.g., C3-C4 chains) found in potent DRD2 ligands. The overall structure might favor binding to other receptors (e.g., muscarinic), leading to poor DRD2 selectivity. The specific phenyl-substituted bicyclic system's conformation might hinder optimal binding pose.\",\n    \"Optimization_for_Source_Molecule\": \"To enhance DRD2 activity, the diphenylmethanol group and methylene linker will be replaced. A known DRD2 pharmacophore, the butyrophenone moiety, will be introduced. Specifically, a 4-(4-fluorophenyl)-4-oxobutyl group will be attached to the basic nitrogen (N1) of the existing substituted bicyclic amine core. This introduces a favorable aromatic substituent (4-fluorophenyl), a carbonyl group (potential H-bond acceptor), and an optimal linker length (propyl chain) while retaining the basic nitrogen.\",\n    \"Final_Target_Molecule\": \"FC1=CC=C(C=C1)C(=O)CCCN1C2CCC1CC(c1ccccc1)C2\"\n  }\n]"
    },
    {
        "src_smiles": "CC1C2Cc3ccc(N)cc3C1(C)CCN2",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The molecule possesses a complex tetracyclic fused ring system containing a piperidine-like tertiary amine, a gem-dimethyl group on a quaternary carbon, and an aniline moiety (primary aromatic amine para to a fusion point).\",\n    \"Property_Analysis\": \"The tertiary amine likely serves as the key basic center interacting with acidic residues (e.g., Asp114) in the DRD2 receptor via ionic/H-bond interactions. The aromatic portion (aniline ring) likely engages in hydrophobic or pi-stacking interactions within the receptor binding pocket. The rigid scaffold determines the relative orientation of these pharmacophoric elements.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The primary aromatic amine (-NH2) group is a potential site for metabolic modification (e.g., oxidation, acetylation), potentially leading to poor pharmacokinetic properties or reactive metabolites. Furthermore, this group might not provide optimal interactions (e.g., H-bonding, hydrophobic) within the specific DRD2 sub-pocket compared to other possible substituents.\",\n    \"Optimization_for_Source_Molecule\": \"To address the limitations, the primary amine group (-NH2) on the aromatic ring will be replaced with a methoxy group (-OCH3). This modification aims to improve metabolic stability, eliminate the aniline-related liability, and introduce a hydrogen bond acceptor/hydrophobic group that might enhance binding affinity at the DRD2 receptor.\",\n    \"Final_Target_Molecule\": \"CC1C2Cc3ccc(OC)cc3C1(C)CCN2\"\n  }\n]"
    },
    {
        "src_smiles": "CC(O)CN1CCN(c2cccc(Cl)c2Cl)CC1",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule CC(O)CN1CCN(c2cccc(Cl)c2Cl)CC1 is an N-arylpiperazine derivative. It features a central piperazine ring. One nitrogen is substituted with a 3,5-dichlorophenyl group. The other nitrogen is substituted with a 1-hydroxyethyl group, introducing a chiral center and a polar hydroxyl group.\",\n    \"Property_Analysis\": \"Arylpiperazines are a well-known scaffold for Dopamine D2 Receptor (DRD2) ligands. The dichlorophenyl group likely engages in hydrophobic and potentially halogen bonding interactions within the receptor binding site. The piperazine core acts as a scaffold, and its basic nitrogen can interact with key acidic residues (like Asp114) in the DRD2 binding pocket. The 1-hydroxyethyl side chain contributes polarity and potential hydrogen bonding interactions.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The 1-hydroxyethyl side chain might be suboptimal for DRD2 binding affinity. It is relatively small and polar, which may not provide sufficient hydrophobic interactions or optimal positioning compared to longer alkyl or functionalized chains found in many potent DRD2 antagonists (e.g., the butyl chain in haloperidol-like structures). The specific stereoisomer might also influence activity, and the racemate might have lower potency.\",\n    \"Optimization_for_Source_Molecule\": \"To potentially improve DRD2 activity, replace the 1-hydroxyethyl side chain with a longer, more lipophilic alkyl chain, such as an n-butyl group. This modification is common in potent DRD2 ligands and can enhance binding by occupying a hydrophobic pocket within the receptor site, potentially increasing van der Waals interactions and overall affinity.\",\n    \"Final_Target_Molecule\": \"CCCCN1CCN(c2cccc(Cl)c2Cl)CC1\"\n  }\n]"
    },
    {
        "src_smiles": "CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1O",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1O is a substituted benzamide. It features a central benzene ring with chloro, amino, and hydroxy substituents, linked via an amide bond to a diethylaminoethyl side chain.\",\n    \"Property_Analysis\": \"Substituted benzamides are a well-known class of compounds exhibiting Dopamine D2 Receptor (DRD2) activity, often acting as antagonists. The diethylaminoethyl side chain and the specific substitution pattern on the aromatic ring (ortho-OH, meta-NH2, para-Cl) influence receptor binding affinity and selectivity.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"While the general structure belongs to a class active at DRD2, the specific combination of substituents (o-OH, m-NH2, p-Cl) might not be optimal for high affinity or selectivity compared to established DRD2 ligands. The ortho-hydroxy group, in particular, might lead to unfavorable interactions, metabolic instability, or reduced oral bioavailability compared to analogous structures like ortho-methoxy benzamides (e.g., sulpiride).\",\n    \"Optimization_for_Source_Molecule\": \"To potentially enhance DRD2 activity and improve drug-like properties, the ortho-hydroxy group (-OH) can be replaced with an ortho-methoxy group (-OCH3). This modification is common in potent DRD2 antagonists (e.g., sulpiride, amisulpride) and often maintains or improves binding affinity while potentially enhancing metabolic stability and pharmacokinetic profile.\",\n    \"Final_Target_Molecule\": \"CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC\"\n  }\n]"
    },
    {
        "src_smiles": "COc1cc(N)c(Cl)cc1C(=O)NC1CCNCC1OC",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule, assuming a plausible interpretation of the SMILES `COc1cc(N)c(Cl)cc1C(=O)NC1CCNCC1OC` as `COc1cc(N)c(Cl)cc1C(=O)N1CCN(C)CC1` (N-methylpiperazine derivative), features a substituted benzamide core. The benzene ring has a methoxy group (OCH3), an amino group (NH2), and a chlorine atom (Cl). This aromatic core is linked via an amide bond to an N-methylpiperazine ring, which contains a crucial basic tertiary amine.\",\n    \"Property_Analysis\": \"Substituted benzamides are a well-known class of Dopamine D2 Receptor (DRD2) antagonists. The N-methylpiperazine moiety provides the necessary basic nitrogen atom, predicted to form a key ionic interaction with the conserved Asp114 residue in the DRD2 binding site. The substituents on the benzene ring (methoxy, chloro, amino) modulate the electronic properties and steric interactions within the binding pocket, influencing overall affinity and selectivity. The N-methyl group contributes to the lipophilicity and interaction within the distal pocket.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"While containing key pharmacophoric elements, the source molecule might have limitations for potent DRD2 activity. The ortho-amino group on the benzene ring is less common in high-affinity DRD2 antagonists compared to other substituents and could potentially reduce binding affinity or introduce metabolic instability. Furthermore, the N-methyl group on the piperazine might be sub-optimal in size for maximizing hydrophobic interactions in the receptor's distal pocket; larger alkyl groups like N-ethyl or N-propyl often show improved affinity in related scaffolds.\",\n    \"Optimization_for_Source_Molecule\": \"To enhance DRD2 activity, the optimization strategy focuses on modifying the N-alkyl group on the piperazine ring, a common approach in DRD2 ligand design. Replacing the N-methyl group with an N-ethyl group is proposed. This modification increases lipophilicity and potentially improves van der Waals interactions within the hydrophobic sub-pocket of the DRD2 receptor, often leading to increased binding affinity while retaining the essential basic nitrogen interaction.\",\n    \"Final_Target_Molecule\": \"COc1cc(N)c(Cl)cc1C(=O)N1CCN(CC)CC1\"\n  }\n]"
    },
    {
        "src_smiles": "O=C(CCc1ccccc1)c1ccccc1O",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule, O=C(CCc1ccccc1)c1ccccc1O (1-(2-hydroxyphenyl)-4-phenylbutan-1-one), features a ketone group linking a 2-hydroxyphenyl ring and a 4-phenylbutyl chain. Key groups include the ketone carbonyl, the phenolic hydroxyl, and two phenyl rings connected by an alkyl chain.\",\n    \"Property_Analysis\": \"High affinity Dopamine D2 Receptor (DRD2) ligands typically possess a basic nitrogen atom capable of forming a salt bridge with Asp114 in the receptor binding pocket, along with specific aromatic interactions and optimal spatial arrangement. The source molecule lacks the crucial basic nitrogen.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The primary limitation for DRD2 activity is the absence of a basic amine group. The ketone and phenol groups are not optimal pharmacophoric features for strong DRD2 binding compared to the canonical features found in known DRD2 ligands.\",\n    \"Optimization_for_Source_Molecule\": \"Introduce a basic nitrogen, often within a cyclic structure like piperazine, which is common in DRD2 ligands. Replace the ketone/hydroxyphenyl moiety with an arylpiperazine structure connected to the phenylalkyl chain. This incorporates the essential basic amine and potentially favorable aromatic interactions. The length of the alkyl chain might also be adjusted.\",\n    \"Final_Target_Molecule\": \"COc1ccccc1N1CCN(CCCCc2ccccc2)CC1\"\n  }\n]"
    },
    {
        "src_smiles": "CN(CC=Cc1ccccc1)Cc1ccc(C2CCCN(C)C2)cc1",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule, CN(CC=Cc1ccccc1)Cc1ccc(C2CCCN(C)C2)cc1, features a central tertiary amine. One nitrogen substituent is a cinnamyl group (3-phenylprop-2-en-1-yl), containing an alkene conjugated to a phenyl ring. The other substituent is a para-substituted benzyl group. The para-substituent is a 1-methylpyrrolidin-2-yl group, which contains a second tertiary amine within a five-membered saturated ring.\",\n    \"Property_Analysis\": \"Dopamine D2 Receptor (DRD2) activity often requires a basic amine group and an aromatic moiety positioned at a specific distance, mimicking dopamine. The source molecule possesses two basic tertiary amines and two phenyl rings. The N-methylpyrrolidine nitrogen and the associated phenyl ring, as well as the central tertiary amine, could potentially interact with the DRD2 binding site.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The cinnamyl group is relatively flexible and its alkene moiety might not be optimal for fitting into the DRD2 binding pocket compared to saturated alkyl or arylalkyl linkers commonly found in potent DRD2 ligands. The overall conformation might not present the pharmacophoric elements (amine, aromatic ring) in the ideal spatial arrangement for high-affinity binding. The specific combination and flexibility of the groups might hinder optimal interaction.\",\n    \"Optimization_for_Source_Molecule\": \"To potentially improve DRD2 activity, the flexible and potentially non-optimal cinnamyl group will be replaced. A common structural motif in DRD2 ligands is a phenethyl group or a related simple alkyl chain connecting the amine to an aromatic ring. Replacing the cinnamyl group (CC=Cc1ccccc1) with a phenethyl group (CCc1ccccc1) maintains an aromatic ring separated by a flexible alkyl chain from the central nitrogen, potentially leading to a better fit and interaction with the DRD2 receptor.\",\n    \"Final_Target_Molecule\": \"CN(CCc1ccccc1)Cc1ccc(C2CCCN(C)C2)cc1\"\n  }\n]"
    },
    {
        "src_smiles": "Fc1ccccc1C1CCN(Cc2nc(CC3CC3)no2)C1",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule consists of a central piperidine ring. One carbon atom of the piperidine is substituted with a 4-fluorophenyl group. The piperidine nitrogen is substituted with a methylene linker attached to a 5-(cyclopropylmethyl)-1,2,4-oxadiazol-3-yl group.\",\n    \"Property_Analysis\": \"The target property is Dopamine D2 Receptor (DRD2) activity. Ligands binding to DRD2 typically require a basic nitrogen atom (present in the piperidine ring) capable of protonation and one or more hydrophobic/aromatic regions positioned at an optimal distance and orientation relative to the basic nitrogen for binding pocket interactions.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The N-substituent, specifically the methylene-oxadiazole-cyclopropylmethyl fragment, might not be optimal in terms of size, shape, lipophilicity, or electronic properties for strong interaction with the DRD2 binding site compared to established pharmacophores. The linker length and the specific heterocycle may limit affinity or introduce unwanted properties.\",\n    \"Optimization_for_Source_Molecule\": \"Replace the N-linked methylene-oxadiazole-cyclopropylmethyl group with a functional group known to enhance DRD2 affinity. A common strategy involves introducing a longer alkyl chain linker terminating in an aromatic group, often incorporating a ketone function (butyrophenone-like motif). We will replace the 'Cc2nc(CC3CC3)no2' group with a 'CCC(=O)c2ccc(F)cc2' (3-(4-fluorobenzoyl)propyl) group.\",\n    \"Final_Target_Molecule\": \"Fc1ccc(C(=O)CCCN2CCC(c3ccccc3F)CC2)cc1\"\n  }\n]"
    },
    {
        "src_smiles": "CCn1c(=O)cc(N2CCN(Cc3ccccc3)CC2)[nH]c1=O",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a 1-ethyl-pyrimidine-2,4(1H,3H)-dione (ethyluracil) core substituted at the 5-position with a piperazine ring. The distal nitrogen of the piperazine ring is N-benzylated.\",\n    \"Property_Analysis\": \"The molecule contains structural motifs potentially relevant to DRD2 activity. The basic nitrogen atom in the piperazine ring and the aromatic benzyl group are common features in known DRD2 ligands, suggesting potential interaction with the receptor's binding site through ionic/hydrogen bonding and hydrophobic interactions, respectively.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The unsubstituted benzyl group lacks specific interactions often found in potent DRD2 ligands, such as halogen or methoxy substituents, which can enhance binding affinity. The uracil core might not be the most optimal scaffold for fitting into the DRD2 binding pocket compared to established pharmacophores.\",\n    \"Optimization_for_Source_Molecule\": \"To potentially improve DRD2 affinity, the benzyl group can be modified. Introducing a substituent like fluorine onto the phenyl ring, specifically at the para-position (4-position), can modulate electronic properties and potentially introduce favorable interactions (e.g., halogen bonding or dipole interactions) within the DRD2 binding site, a common strategy in optimizing CNS ligands.\",\n    \"Final_Target_Molecule\": \"CCn1c(=O)cc(N2CCN(Cc3ccc(F)cc3)CC2)[nH]c1=O\"\n  }\n]"
    },
    {
        "src_smiles": "c1cc(OCCCN2CCCCC2)ccc1CN1CCCCC1",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a central 1,3-disubstituted (meta) benzene ring. One substituent is an (piperidin-1-yl)propoxy group (OCCCN1CCCCC1). The other substituent is a (piperidin-1-yl)methyl group (CN1CCCCC1). Key features include the aromatic core, an ether linkage, an alkyl chain, a methylene linker, and two terminal basic piperidine rings.\",\n    \"Property_Analysis\": \"The molecule contains structural motifs common in DRD2 ligands: an aromatic system, linker chains of appropriate length (3 atoms C-C-C via ether, 1 atom C via methylene), and terminal basic amine groups (piperidines). These features suggest potential interaction with the DRD2 receptor, which typically binds ligands with an aromatic moiety and a basic nitrogen atom separated by a specific distance.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The presence of two distinct side chains, both terminating in basic piperidine groups, introduces significant flexibility and multiple potential binding modes. This complexity can lead to reduced binding affinity due to entropic penalties or non-optimal fit. The ether linkage in the propoxy chain might not be the most favorable interaction type or provide the ideal geometry for the DRD2 binding site compared to other known linkers like ketones or amides. The combination of two basic amines might also lead to poor selectivity or undesirable ADME properties.\",\n    \"Optimization_for_Source_Molecule\": \"To improve DRD2 activity, optimization focuses on modifying one of the linker regions to incorporate features known to enhance binding. Replace the ether oxygen atom in the propoxy side chain with a carbonyl group (C=O). This converts the linker to a butyrophenone-like fragment (-C(=O)CCCN-), a common and often potent pharmacophore found in many established DRD2 antagonists (e.g., haloperidol). This change introduces a potential hydrogen bond acceptor and alters the conformation and electronic properties of the side chain, potentially leading to a better fit and stronger interaction with the DRD2 receptor.\",\n    \"Final_Target_Molecule\": \"c1cc(C(=O)CCCN2CCCCC2)ccc1CN1CCCCC1\"\n  }\n]"
    },
    {
        "src_smiles": "O=C(Cc1ccccc1)NC1CCN(Cc2ccccc2)CC1",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule, O=C(Cc1ccccc1)NC1CCN(Cc2ccccc2)CC1, consists of a phenylacetamide moiety linked via an amide bond to the 4-amino position of an N-benzylpiperidine ring. Key features include two unsubstituted phenyl rings, an amide linker, and a tertiary amine within the piperidine ring.\",\n    \"Property_Analysis\": \"The molecule contains structural elements common in CNS-active compounds, particularly the N-substituted piperidine ring which is a frequent pharmacophore interacting with aminergic GPCRs like dopamine receptors. The basic nitrogen of the piperidine can interact with acidic residues in the receptor. The aromatic rings can engage in hydrophobic and pi-stacking interactions. The amide group provides hydrogen bonding capability.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The unsubstituted phenylacetamide group may lack specific interactions required for high DRD2 affinity and selectivity. Potent DRD2 ligands often feature specific substitution patterns (e.g., halogens, methoxy groups) on aromatic rings or employ different aromatic systems (e.g., benzamides, heterocycles) linked to the basic amine core. The overall conformation and distance between the pharmacophoric elements (aromatic rings, basic nitrogen) might not be optimal for DRD2 binding compared to established DRD2 ligands.\",\n    \"Optimization_for_Source_Molecule\": \"To enhance DRD2 activity, the phenylacetamide group can be replaced with a moiety known to confer higher affinity. A common strategy involves replacing it with a substituted benzamide group. Introducing a halogen, such as chlorine, at the para-position of the benzoyl ring is a frequent modification in DRD2 antagonists (e.g., Metoclopramide analogues). This modification aims to improve binding interactions within the DRD2 pocket.\",\n    \"Final_Target_Molecule\": \"O=C(c1ccc(Cl)cc1)NC1CCN(Cc2ccccc2)CC1\"\n  }\n]"
    },
    {
        "src_smiles": "CC(C)C(=O)NC1CCN(Cc2ccccc2)CC1",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule contains an N-benzylpiperidine core structure. The piperidine nitrogen is substituted with a benzyl group. One of the piperidine carbons bears an isobutyramide group (-NH-CO-CH(CH3)2). Key features include the basic piperidine nitrogen, the aromatic benzyl group, and the secondary amide linkage.\",\n    \"Property_Analysis\": \"DRD2 ligands often possess a basic amine (like the piperidine nitrogen) and an aromatic moiety (like the benzyl group) separated by an appropriate linker, capable of interacting with key residues in the receptor binding pocket. The amide group can also participate in hydrogen bonding.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The isobutyramide group is relatively small and non-polar, potentially lacking specific interactions (e.g., hydrogen bonding, pi-stacking) often required for high DRD2 affinity. The simple benzyl group might also offer suboptimal interactions compared to more complex or substituted aromatic systems found in potent DRD2 ligands.\",\n    \"Optimization_for_Source_Molecule\": \"Replace the isobutyryl group with a moiety known to enhance DRD2 binding. A common strategy involves incorporating a substituted benzamide group. Replacing the isobutyramide with a 4-fluorobenzamide introduces an additional aromatic ring with an electron-withdrawing group (F), which can enhance potency and potentially improve pharmacokinetic properties. This creates a structure more analogous to known DRD2 antagonists.\",\n    \"Final_Target_Molecule\": \"O=C(NC1CCN(Cc2ccccc2)CC1)c3ccc(F)cc3\"\n  }\n]"
    },
    {
        "src_smiles": "CN1CCN(c2cc(-c3cccnc3)nc(N)n2)CC1",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The molecule features a 2,4-diaminopyrimidine core. Position 5 is substituted with a 3-pyridinyl group. Position 6 is substituted with a 4-methylpiperazin-1-yl group. Key functional groups include the basic methylpiperazine nitrogen, the pyrimidine nitrogens, the amino group, and the pyridine nitrogen.\",\n    \"Property_Analysis\": \"DRD2 ligands typically require a basic nitrogen atom for interaction with Asp114 in the binding site and hydrophobic/aromatic groups to occupy specific pockets. The methylpiperazine nitrogen can serve as the basic center. The pyridinyl and pyrimidine rings provide aromatic/hydrophobic character.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The specific arrangement and electronic properties of the pyridinyl-diaminopyrimidine scaffold may not be optimal for fitting into the DRD2 binding site compared to established DRD2 pharmacophores. The electron-poor nature of the pyridine ring and its specific vector relative to the basic nitrogen might limit favorable interactions within the hydrophobic pockets of DRD2.\",\n    \"Optimization_for_Source_Molecule\": \"To enhance DRD2 activity, replace the 3-pyridinyl group with a moiety known to interact favorably with the hydrophobic regions of the DRD2 receptor, such as a substituted phenyl ring. A 3,4-dichlorophenyl group is chosen as it is frequently found in potent DRD2 ligands, potentially improving hydrophobic and electronic interactions within the binding site while maintaining the essential basic nitrogen of the methylpiperazine.\",\n    \"Final_Target_Molecule\": \"CN1CCN(c2cc(-c3ccc(Cl)c(Cl)c3)nc(N)n2)CC1\"\n  }\n]"
    },
    {
        "src_smiles": "O=C(CN1CCN(CCc2ccccc2)CC1)C(O)(c1ccccc1)C1CCC1",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a central piperazine ring. One nitrogen is substituted with a phenethyl group (N-CH2CH2Ph). The other nitrogen is substituted with an N-acylmethyl group, specifically N-CH2C(=O)C(OH)(Ph)(Cyclohexyl). Key functional groups include the piperazine (basic amine), phenyl rings (aromatic), an amide, and a tertiary alcohol.\",\n    \"Property_Analysis\": \"DRD2 receptor ligands often contain a basic nitrogen (present in the piperazine) capable of protonation and an aromatic moiety. The phenethylpiperazine core is found in some CNS-active compounds. The complex substituent C(OH)(Ph)(Cyclohexyl) attached via the acylmethyl linker contributes significant bulk and conformational flexibility.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The large, sterically demanding C(OH)(Ph)(Cyclohexyl) group attached to the amide is likely suboptimal for binding to the typically more constrained DRD2 active site. Its specific combination of features (amide, tertiary alcohol, phenyl, cyclohexyl) does not strongly resemble known high-affinity DRD2 pharmacophores. The overall shape and electronic distribution may not favor strong receptor interaction.\",\n    \"Optimization_for_Source_Molecule\": \"Replace the complex N-acylmethyl substituent [-CH2C(=O)C(OH)(Ph)(Cyclohexyl)] with a group known to confer DRD2 activity, while retaining the phenethylpiperazine core. A common strategy involves incorporating aryl or heteroaryl groups known to interact favorably with the receptor. Specifically, replacing the complex amide-derived group with a benzisothiazolylmethyl group, often found in potent DRD2 antagonists (e.g., related to ziprasidone). This introduces a recognized pharmacophore element while maintaining the piperazine core and a short linker.\",\n    \"Final_Target_Molecule\": \"c1ccc(CCN2CCN(Cc3nc4ccccc4s3)CC2)cc1\"\n  }\n]"
    },
    {
        "src_smiles": "OC(COc1ccc(-n2cncn2)cc1)CN1CCc2ccccc2C1",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a tetrahydroisoquinoline (THIQ) moiety linked via a methylene bridge to a chiral secondary alcohol center. This chiral center is further connected through an ether linkage to a phenyl ring substituted with a 1,2,4-triazol-1-yl group in the para position.\",\n    \"Property_Analysis\": \"The THIQ core is a known pharmacophore that can mimic dopamine and interact with DRD2. The nitrogen atom can serve as a basic center interacting with acidic residues (e.g., Asp). The phenyl-triazole part likely engages in hydrophobic and potentially pi-stacking interactions within the receptor binding pocket. The hydroxyl group offers a hydrogen bonding site.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The 1,2,4-triazole substituent on the phenyl ring might not be optimal for DRD2 affinity. While it provides polarity and H-bond acceptors, other substituents (e.g., halogens, small electron-withdrawing groups) are often found in potent DRD2 ligands and might offer better interactions with specific subpockets. The overall electronic and steric profile of the para-triazole group might not be ideal for maximizing binding affinity.\",\n    \"Optimization_for_Source_Molecule\": \"To enhance DRD2 activity, replace the para-triazole group on the phenyl ring with a substituent more commonly associated with potent DRD2 ligands, such as a halogen. Replacing the triazole with a chlorine atom (Cl) in the para position maintains interaction with a similar region but alters the electronic properties and potential hydrophobic interactions, which could lead to improved affinity.\",\n    \"Final_Target_Molecule\": \"OC(COc1ccc(Cl)cc1)CN1CCc2ccccc2C1\"\n  }\n]"
    },
    {
        "src_smiles": "COc1ccc(CN2CCC(C(=O)Nc3cc(Cl)c(N)cc3OC)CC2)cc1",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a central piperidine ring. The piperidine nitrogen is substituted with a p-methoxybenzyl group. The 4-position of the piperidine ring carries an amide substituent, derived from 4-amino-3-chloro-5-methoxyaniline. Key pharmacophoric elements include the basic piperidine nitrogen, the amide linker (potential H-bond donor/acceptor), and two aromatic rings with various substituents (methoxy, chloro, amino).\",\n    \"Property_Analysis\": \"The molecule possesses structural motifs commonly found in DRD2 ligands, such as the basic amine (piperidine nitrogen) capable of interacting with Asp114 in the DRD2 binding site, and aromatic groups for potential hydrophobic/pi-stacking interactions. The amide group provides rigidity and potential hydrogen bonding interactions. The overall structure resembles certain classes of antipsychotics or CNS agents, suggesting potential, albeit likely non-optimal, DRD2 affinity.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The p-methoxybenzyl group on the piperidine nitrogen might not be optimal for occupying the lipophilic pocket targeted by N-substituents in potent DRD2 ligands; longer alkyl linkers and different aromatic systems (e.g., dichlorophenyl) are often preferred. The complex 4-amino-3-chloro-5-methoxyaniline moiety attached via the amide bond is bulky and flexible, potentially leading to suboptimal fit, unfavorable interactions, or undesired off-target effects compared to more established pharmacophores like benzamides or heterocyclic systems (e.g., benzisoxazole). The combination of these specific substituents may result in moderate affinity or poor selectivity.\",\n    \"Optimization_for_Source_Molecule\": \"To enhance DRD2 activity, modifications inspired by potent ligands like atypical antipsychotics are proposed. 1) Replace the p-methoxybenzyl group on the piperidine nitrogen with a longer linker and a different aromatic group, such as a 4-(2,4-dichlorophenyl)butyl chain, known to interact favorably with the DRD2 receptor. 2) Replace the complex amide substituent at the piperidine 4-position with a more established DRD2 pharmacophore, such as a 3-(1,2-benzisoxazolyl) group, which is found in highly potent antagonists like Risperidone and Paliperidone. This group offers rigidity and specific interactions within the binding site.\",\n    \"Final_Target_Molecule\": \"Clc1ccc(Cl)cc1CCCCN1CCC(CC1)c2noc3ccccc23\"\n  }\n]"
    },
    {
        "src_smiles": "CN1C2CCC1CC(Oc1ccc(C(F)(F)F)cc1)(c1ccccc1)C2",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule, CN1C2CCC1CC(Oc1ccc(C(F)(F)F)cc1)(c1ccccc1)C2, features a rigid bicyclic tropane core with a tertiary N-methyl group. Attached to the tropane core at position 3 via a quaternary carbon are two aromatic rings: one phenyl ring and one para-trifluoromethylphenyl ring, linked through an ether oxygen atom to the tropane core.\",\n    \"Property_Analysis\": \"Tropane alkaloids and their derivatives are known scaffolds for targeting monoamine receptors, including dopamine receptors like DRD2. The basic nitrogen of the tropane core is expected to interact with acidic residues (e.g., Aspartic acid) in the DRD2 binding site. The aromatic rings likely occupy hydrophobic pockets within the receptor. The trifluoromethyl group influences lipophilicity and electronic properties, potentially affecting binding affinity and selectivity.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The current arrangement and substitution pattern of the aromatic rings might not be optimal for high-affinity DRD2 binding. The unsubstituted phenyl ring lacks specific interactions that could enhance binding. Furthermore, the overall lipophilicity contributed by the trifluoromethyl group and the diaryl system might need adjustment for better pharmacokinetic properties or selectivity profiles. The ether linkage might also contribute to suboptimal positioning or metabolic instability.\",\n    \"Optimization_for_Source_Molecule\": \"To potentially enhance DRD2 activity, we propose introducing a substituent on the unsubstituted phenyl ring to improve interactions within the receptor's hydrophobic pocket. Halogenation, particularly chlorination at the para-position, is a common strategy in DRD2 ligand design known to often increase affinity. This modification aims to improve binding without drastically altering the core structure or significantly increasing lipophilicity compared to other potential modifications.\",\n    \"Final_Target_Molecule\": \"CN1C2CCC1CC(Oc1ccc(C(F)(F)F)cc1)(c1ccc(Cl)cc1)C2\"\n  }\n]"
    },
    {
        "src_smiles": "O=C(c1ccc(-c2ccccc2)cc1)N1CCN(c2ccccc2F)CC1",
        "prop": "drd",
        "json_results": "[{\n  \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a central benzoyl group linked to a piperazine ring. One nitrogen of the piperazine is N-acylated by the benzoyl group, which itself is substituted at the para position with a biphenyl moiety. The other piperazine nitrogen is attached to a 4-fluorophenyl group. Key components are the N-arylpiperazine core, the amide linker, and the biphenyl substituent.\",\n  \"Property_Analysis\": \"N-arylpiperazine derivatives are well-known scaffolds interacting with Dopamine D2 receptors (DRD2). The basic nitrogen in the piperazine typically forms an ionic interaction with an acidic residue (e.g., Asp) in the receptor. The aromatic rings (fluorophenyl and biphenyl) likely engage in hydrophobic and pi-stacking interactions. The overall shape, electronic distribution, and conformational flexibility dictated by these groups determine DRD2 binding affinity and functional activity.\",\n  \"Limitation_in_Source_Molecule_for_Property\": \"The large and relatively flexible biphenyl group at the para position of the benzoyl ring might not be optimal for high-affinity binding to DRD2. Its size could lead to steric clashes or suboptimal positioning within the binding pocket compared to known DRD2 ligands which often feature different substituents or linker types. The flexibility might also incur an entropic penalty upon binding.\",\n  \"Optimization_for_Source_Molecule\": \"To potentially improve DRD2 activity, the bulky and flexible para-biphenyl group will be replaced. A common optimization strategy for DRD2 ligands involves modifying distal hydrophobic groups. We replace the biphenyl group with a smaller, less flexible, and potentially H-bond accepting para-methoxy group. This simplification reduces lipophilicity and size, potentially leading to a better fit and improved interaction profile within the DRD2 binding site.\",\n  \"Final_Target_Molecule\": \"COc1ccc(C(=O)N2CCN(c3ccccc3F)CC2)cc1\"\n}]"
    },
    {
        "src_smiles": "CC(C)c1ccccc1OCCN1CCC(NS(=O)(=O)c2ccccc2)CC1",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The molecule features an isopropylphenyl group linked via an ethoxy chain (-O-CH2-CH2-) to a piperidine ring. The piperidine ring is substituted at the 4-position with a sulfonamide group (-NH-SO2-), which is further attached to a phenyl ring. Key functional groups include: ether, tertiary amine (piperidine nitrogen), secondary sulfonamide, and two aromatic rings.\",\n    \"Property_Analysis\": \"The structure contains elements common in DRD2 ligands: a basic nitrogen (piperidine) likely interacting with acidic residues (e.g., Asp114 in TM3), an aromatic group (isopropylphenyl) for hydrophobic/pi-stacking interactions, and a linker connecting them. The sulfonamide group acts as a hydrogen bond donor (N-H) and acceptor (O=S=O) and positions the terminal phenyl ring in a specific region of the binding site.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The unsubstituted phenyl ring on the sulfonamide group might lack specific interactions (e.g., halogen bonding, stronger H-bonds, targeted hydrophobic interactions) possible with substituted aryl groups, potentially limiting binding affinity or selectivity. The isopropylphenyl group's size and hydrophobicity might also not be optimal for the specific subpocket it occupies compared to other aromatic systems.\",\n    \"Optimization_for_Source_Molecule\": \"To potentially enhance receptor interaction, particularly within the pocket accommodating the sulfonylaryl group, replace the terminal phenyl ring with a 4-fluorophenyl group. Fluorine substitution can modulate electronic properties and potentially engage in favorable halogen bond interactions or fill a small hydrophobic pocket without significantly increasing steric bulk.\",\n    \"Final_Target_Molecule\": \"CC(C)c1ccccc1OCCN1CCC(NS(=O)(=O)c2ccc(F)cc2)CC1\"\n  }\n]"
    },
    {
        "src_smiles": "CCN1CCN(C2=C(NC(=O)c3ccccc3)C(=O)c3ccccc3C2=O)CC1",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule, CCN1CCN(C2=C(NC(=O)c3ccccc3)C(=O)c3ccccc3C2=O)CC1, features an N-ethylpiperazine moiety attached to a vinyl position of a 2-amino-1,4-naphthoquinone derivative. The amino group is further substituted with a benzoyl group, forming a benzamide linkage.\",\n    \"Property_Analysis\": \"The target property is DRD2 (Dopamine D2 Receptor) activity. Key pharmacophoric features for DRD2 ligands often include a basic amine (present here as the piperazine nitrogen) and lipophilic aromatic regions. The N-ethylpiperazine is a common motif in CNS agents, potentially interacting with the receptor. The overall structure combines polar (carbonyls, amide) and non-polar (aromatic rings, ethyl group) features, influencing solubility, membrane permeability, and receptor binding.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The large, relatively planar anthraquinone-like core combined with the specific vinylogous amide linkage might not present the optimal geometry or electronic distribution for high-affinity DRD2 binding compared to established DRD2 pharmacophores (e.g., butyrophenones, ergolines). The unsubstituted benzamide group might lack specific interactions favored by the DRD2 binding site. Potential off-target activity or poor pharmacokinetic properties (like brain penetration) could also be limitations.\",\n    \"Optimization_for_Source_Molecule\": \"To potentially enhance DRD2 activity, modifications focus on the substituents known to interact with the receptor. Replacing the unsubstituted benzoyl group with a substituted version, specifically a 4-fluorobenzoyl group, is a common strategy in DRD2 ligand design. The fluorine atom can enhance binding affinity through favorable interactions (e.g., lipophilic or electrostatic) within the receptor pocket without drastically altering the molecule's core structure.\",\n    \"Final_Target_Molecule\": \"CCN1CCN(C2=C(NC(=O)c3ccc(F)cc3)C(=O)c3ccccc3C2=O)CC1\"\n  }\n]"
    },
    {
        "src_smiles": "CCC(CNC(=O)c1ccccc1Br)N1CCc2ccccc2C1",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule contains a tetrahydroisoquinoline (THIQ) core, a chiral center substituted with an ethyl group, a secondary amine linked via an N-methyl group to an amide moiety, and a meta-bromophenyl ring attached to the amide carbonyl.\",\n    \"Property_Analysis\": \"The THIQ nitrogen serves as the basic amine, a common feature for DRD2 ligand interaction (likely binding to Asp114). The bromophenyl amide portion likely interacts with hydrophobic and aromatic residues within the DRD2 binding pocket. The overall structure resembles known scaffolds for dopamine receptor ligands, suggesting potential, albeit unoptimized, activity.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The amide linker introduces rigidity and hydrogen bonding potential that may not be optimal for DRD2 binding compared to more flexible alkyl or ether linkers commonly found in potent ligands. The meta-bromo substitution pattern on the phenyl ring might not be ideal for hydrophobic pocket interactions or pi-stacking. The distance and conformation imposed by the linker between the THIQ basic nitrogen and the aromatic ring might be suboptimal for fitting the DRD2 pharmacophore.\",\n    \"Optimization_for_Source_Molecule\": \"To improve DRD2 activity, replace the rigid amide linker with a more flexible three-carbon alkyl chain (-CH2CH2CH2-). Modify the aromatic substitution by replacing the meta-bromo group with a para-chloro group, which is frequently observed in potent DRD2 ligands and often provides favorable interactions within the binding site. The core THIQ and the ethyl group on the chiral center are retained initially.\",\n    \"Final_Target_Molecule\": \"CCC(CNCCCc1ccc(Cl)cc1)N1CCc2ccccc2C1\"\n  }\n]"
    },
    {
        "src_smiles": "CCOC(=O)c1cc2cc(C3(Cc4ccccc4)CCNC3)ccc2[nH]1",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features an indole core fused with a benzene ring. An ethyl ester group is attached at position 5 of the indole. A spirocyclic system is attached at position 7, consisting of a piperidine ring fused via a spiro carbon, which also bears a benzyl group. The piperidine nitrogen is secondary.\",\n    \"Property_Analysis\": \"The molecule possesses key features often found in DRD2 ligands: a basic nitrogen (piperidine NH) capable of protonation and interaction with the receptor's acidic residues (e.g., Asp114), and aromatic rings (indole, benzyl) for hydrophobic and pi-stacking interactions. The relative positioning of the amine and aromatic groups is crucial for binding affinity.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The secondary amine in the piperidine ring might lead to lower affinity or selectivity compared to specifically substituted tertiary amines common in potent DRD2 ligands. It might also be prone to metabolic N-dealkylation if substituted or conjugation if unsubstituted. The ethyl ester group at position 5 might introduce unfavorable steric bulk or polarity, potentially hindering optimal fit within the DRD2 binding pocket or leading to metabolic instability (hydrolysis). The overall conformation of the spiro-piperidine-benzyl moiety might not perfectly align with the optimal geometry for the DRD2 binding site.\",\n    \"Optimization_for_Source_Molecule\": \"To potentially improve DRD2 activity, two modifications are proposed: 1) Replace the secondary amine with a tertiary amine by N-methylation, which is common in many DRD2 ligands and can enhance binding affinity and metabolic stability. 2) Remove the ethyl ester group to reduce potential steric clashes, improve the lipophilicity profile, and simplify the structure, focusing on the core pharmacophore elements required for DRD2 interaction.\",\n    \"Final_Target_Molecule\": \"CN1CCC(c2cc3cc[nH]c3cc2)(Cc2ccccc2)CC1\"\n  }\n]"
    },
    {
        "src_smiles": "CN1CCN(CC(=O)Nc2ccc(Sc3ccc(Cl)cc3)cc2)CC1",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features an N-methylpiperazine ring connected via an acetamide linker (-CC(=O)NH-) to a para-substituted aniline. The aniline nitrogen is part of the amide. The aniline ring is further substituted at the para position with a sulfide linker (-S-) connecting to a 4-chlorophenyl ring. Key components are: N-methylpiperazine (basic amine), acetamide linker, diphenyl sulfide core, chloro substituent.\",\n    \"Property_Analysis\": \"DRD2 activity often relies on a basic amine (like the piperazine nitrogen) capable of interacting with key residues (e.g., Asp114) and an appropriate spatial arrangement relative to hydrophobic/aromatic regions that interact with the receptor binding pocket. The distance between the basic amine and the aromatic features is critical.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The diphenyl sulfide core, while providing aromaticity and lipophilicity, might not be optimal for fitting into the DRD2 binding pocket compared to established pharmacophores. The acetamide linker imposes specific conformational constraints and hydrogen bonding properties that may not align perfectly with DRD2 binding requirements. The overall length and flexibility between the basic N-methylpiperazine and the distal aromatic ring (chlorophenyl) might be suboptimal for potent DRD2 interaction.\",\n    \"Optimization_for_Source_Molecule\": \"To improve DRD2 activity, we replace the acetamide linker and diphenyl sulfide core with a structure more reminiscent of known potent DRD2 ligands, like butyrophenones. We introduce a 4-carbon keto linker (-CCCC(=O)-) directly attached to the piperazine nitrogen. This linker provides a more favorable length for DRD2 binding. The complex diphenyl sulfide core is replaced with a simpler para-fluorophenyl group, a common motif in potent DRD2 antagonists, attached to the ketone. This modification aims to optimize the distance, conformation, and aromatic interactions within the DRD2 binding site.\",\n    \"Final_Target_Molecule\": \"CN1CCN(CCCC(=O)c2ccc(F)cc2)CC1\"\n  }\n]"
    },
    {
        "src_smiles": "CN1C2CCC1CC(Oc1ccc(C(F)(F)F)cc1)(c1ccccc1)C2",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule, CN1C2CCC1CC(Oc1ccc(C(F)(F)F)cc1)(c1ccccc1)C2, features a tropane scaffold (8-methyl-8-azabicyclo[3.2.1]octane). The key characteristic is the C3 position, which is a quaternary carbon substituted with both a phenyl group and a 4-(trifluoromethyl)phenoxy group. The nitrogen atom (N8) is methylated.\",\n    \"Property_Analysis\": \"The tropane scaffold is common in CNS-active agents and ligands targeting monoamine transporters and receptors, including DRD2. The basic nitrogen can form ionic interactions. The aromatic groups (phenyl and phenoxy-CF3) contribute lipophilicity and potential pi-stacking or hydrophobic interactions within the receptor binding site. The electron-withdrawing CF3 group on the phenoxy ring influences electronic properties and may interact with specific receptor residues.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The primary limitation for potent DRD2 activity is likely the sterically demanding quaternary substitution at C3. This bulky arrangement may prevent optimal fitting and interaction within the relatively constrained DRD2 binding pocket compared to typical DRD2 ligands which often feature a single substituent (like an aryl or related group) at C3, usually in the beta (axial) configuration. The simultaneous presence of both large groups could lead to steric clashes or suboptimal orientation of key pharmacophoric features.\",\n    \"Optimization_for_Source_Molecule\": \"Simplify the C3 substitution to reduce steric bulk and better mimic established DRD2 pharmacophores. Remove the quaternary center by eliminating one substituent (e.g., the phenyl group) and modifying the other. Replace the complex C3 substitution with a single aryl group known to confer affinity at dopamine receptors/transporters, such as a 3,4-dichlorophenyl group. Ensure the C3 substituent is in the beta configuration, which is generally more favorable for DRD2 activity in tropane derivatives. Retain the N-methyl tropane core.\",\n    \"Final_Target_Molecule\": \"CN1[C@H]2CC[C@@H]1C[C@@H](C2)c1ccc(Cl)c(Cl)c1\"\n  }\n]"
    },
    {
        "src_smiles": "Cc1nc(-c2ccccc2)c(C(=O)N2CCN(c3c(C)cccc3C)CC2)o1",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a central 5-methyl-2-phenyl-oxazole core. Attached to the oxazole at position 4 is a carboxamide linker (-C(=O)N-). This linker connects to a piperazine ring, which is further N-substituted with a 2,6-dimethylphenyl group.\",\n    \"Property_Analysis\": \"The molecule contains key pharmacophoric features often found in DRD2 ligands: a basic nitrogen atom within the piperazine ring, capable of forming ionic interactions, and multiple aromatic rings (phenyl, oxazole, dimethylphenyl) that can engage in hydrophobic and pi-stacking interactions within the receptor binding site. The overall structure suggests potential CNS activity.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The specific combination and spatial arrangement of the oxazole core, phenyl group, and the 2,6-dimethylphenylpiperazine moiety may not be optimal for high-affinity binding to the DRD2 receptor. The steric bulk of the 2,6-dimethylphenyl group might hinder optimal placement in the binding pocket. The oxazole scaffold itself might not be as favorable as other cores commonly found in potent DRD2 ligands.\",\n    \"Optimization_for_Source_Molecule\": \"To potentially improve DRD2 activity, the terminal aromatic substituent on the piperazine nitrogen will be modified. Replacing the 2,6-dimethylphenyl group with a 2,3-dichlorophenyl group, a moiety present in known potent DRD2 ligands like Aripiprazole, could enhance binding affinity through altered electronic properties (electron-withdrawing halogens) and potentially improved hydrophobic interactions within a specific subpocket of the DRD2 receptor.\",\n    \"Final_Target_Molecule\": \"Cc1nc(-c2ccccc2)c(C(=O)N2CCN(c3ccc(Cl)c(Cl)c3)CC2)o1\"\n  }\n]"
    },
    {
        "src_smiles": "COc1ccc(CC2NCCc3c2[nH]c2ccc(SC)cc32)cc1OC",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a central tetrahydro-beta-carboline core. A dimethoxybenzyl group is attached via an ethyl linker to the carbon adjacent to the secondary amine nitrogen. The indole moiety of the beta-carboline is substituted with a methylthio (SC) group.\",\n    \"Property_Analysis\": \"The molecule possesses key pharmacophoric elements potentially relevant for DRD2 activity: an aromatic region (dimethoxybenzyl and indole rings), a basic nitrogen center (the secondary amine within the tetrahydro-beta-carboline ring), and a relatively rigid scaffold defining the spatial relationship between these elements. The methylthio group contributes to lipophilicity and potentially influences electronic distribution on the indole ring.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The methylthio (SC) group on the indole ring might not be optimal for DRD2 binding. While contributing to lipophilicity, it lacks strong polar interactions and its electron-donating nature (via resonance) might be less favorable compared to electron-withdrawing groups often found in potent DRD2 ligands at similar positions. Its bulk and specific orientation could also lead to suboptimal fit or steric hindrance within the receptor binding pocket.\",\n    \"Optimization_for_Source_Molecule\": \"To potentially improve DRD2 affinity and modulate electronic properties, the methylthio (SC) group will be replaced with a Chlorine (Cl) atom. Chlorine is a common bioisostere, it is electron-withdrawing, similar in size, and frequently enhances binding affinity or pharmacokinetic properties in GPCR ligands, including DRD2 antagonists/agonists.\",\n    \"Final_Target_Molecule\": \"COc1ccc(CC2NCCc3c2[nH]c2ccc(Cl)cc32)cc1OC\"\n  }\n]"
    },
    {
        "src_smiles": "O=c1cc(-c2ccccc2)oc2cc(OCCN3CCOCC3)cc(O)c12",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule is a coumarin derivative. Key features include: a coumarin core (fused pyrone and benzene rings), a phenyl substituent at position 3 of the pyrone ring, a hydroxyl group on the fused benzene ring, and an ether-linked side chain containing a morpholine ring attached via an ethyl linker (OCCN) to the fused benzene ring.\",\n    \"Property_Analysis\": \"DRD2 activity often requires specific pharmacophoric elements. These typically include a basic nitrogen atom capable of protonation (like the morpholine nitrogen) separated from an aromatic system by an appropriate linker (usually 2-4 atoms). Hydrophobic interactions with aromatic rings and potential hydrogen bonding interactions are also crucial for binding affinity and selectivity.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The coumarin core might not be an optimal scaffold for DRD2 binding compared to established pharmacophores (e.g., phenothiazines, butyrophenones, substituted piperazines/piperidines). The morpholine group, while basic, might not provide the optimal basicity or steric fit compared to piperazine or piperidine derivatives often found in potent DRD2 ligands. The flexibility and length of the OCCN linker might not position the basic nitrogen optimally within the receptor binding site. The unsubstituted phenyl ring may lack specific interactions.\",\n    \"Optimization_for_Source_Molecule\": \"To potentially improve DRD2 activity, the morpholine ring, which is a relatively weak base and has specific conformational constraints, can be replaced with a piperazine ring. Introducing an N-methyl group on the distal nitrogen of the piperazine can enhance basicity and potentially introduce favorable interactions often seen in CNS ligands, including some DRD2 modulators. This retains the core structure but modifies the basic amine moiety, a key element for DRD2 interaction.\",\n    \"Final_Target_Molecule\": \"O=c1cc(-c2ccccc2)oc2cc(OCCN3CCN(C)CC3)cc(O)c12\"\n  }\n]"
    },
    {
        "src_smiles": "COC(=O)C1CCN(CCCN2CCN(c3ccc(F)cc3)CC2)CC1",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a central piperidine ring substituted with a methyl ester. This piperidine is N-linked via a propyl chain to a piperazine ring, which is further N-substituted with a 4-fluorophenyl group. Key features include two basic nitrogen atoms (piperidine and distal piperazine nitrogen), a flexible propyl linker, an ester group, and an arylpiperazine moiety.\",\n    \"Property_Analysis\": \"The 4-fluorophenylpiperazine moiety is a known pharmacophore found in several CNS active compounds, including some DRD2 ligands. The presence of basic nitrogens allows potential ionic interactions with acidic residues (like Asp) in the DRD2 binding site. The overall structure suggests potential interaction with aminergic GPCRs, including dopamine receptors.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The methyl ester group on the piperidine ring might not be optimal for high-affinity DRD2 binding. Many potent DRD2 ligands feature amides, alcohols, or other heterocyclic groups at similar positions, which may engage in more specific hydrogen bonding or hydrophobic interactions within the receptor pocket. The ester group could also be susceptible to hydrolysis in vivo, potentially limiting duration of action.\",\n    \"Optimization_for_Source_Molecule\": \"To potentially enhance DRD2 activity, the methyl ester group can be replaced with a functional group known to improve binding affinity in related DRD2 ligands. Replacing the ester with a metabolically more stable and potentially better interacting carboxamide, specifically an N-ethyl carboxamide (`-C(=O)NHCH2CH3`), introduces a hydrogen bond donor (N-H) and maintains a hydrogen bond acceptor (C=O), potentially leading to improved receptor interactions.\",\n    \"Final_Target_Molecule\": \"CCNC(=O)C1CCN(CCCN2CCN(c3ccc(F)cc3)CC2)CC1\"\n  }\n]"
    },
    {
        "src_smiles": "CCN(CC)CCCNC1c2cc(OC)ccc2OCc2ncccc21",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule, CCN(CC)CCCNC1c2cc(OC)ccc2OCc2ncccc21, interpreted as COc1ccc2c(c1)COc1ncccc1[C@H]1CCCN(CC)CC, features a fused tricyclic core (dihydrofuranobenzopyridine), a flexible propyl amine linker (-CCCN-), and a terminal diethylamino group (-N(CC)CC). The core contains a pyridine ring fused to a dihydrofuran ring, which is further fused to a methoxy-substituted benzene ring. The linker is attached to a chiral carbon atom bridging the dihydrofuran and pyridine rings.\",\n    \"Property_Analysis\": \"The molecule possesses key pharmacophoric features often associated with DRD2 ligands: an aromatic/heteroaromatic system (the tricyclic core) and a basic amine (diethylamino group) separated by a linker. The basic amine can interact with acidic residues (e.g., Asp114) in the DRD2 binding site, while the aromatic core interacts with hydrophobic and aromatic residues. The methoxy group can influence binding affinity and selectivity through electronic and steric effects.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The flexible propyl amine linker may adopt multiple conformations, not all of which are optimal for high-affinity binding, leading to potential entropy loss upon binding. The terminal diethylamino group might not be the ideal size or basicity for optimal interaction within the DRD2 binding pocket compared to established DRD2 pharmacophores like arylpiperazines. The specific methoxy substitution pattern on the benzofuran part might not be optimal.\",\n    \"Optimization_for_Source_Molecule\": \"To improve DRD2 affinity, the flexible linker and terminal amine will be replaced with a more constrained and established DRD2 pharmacophore element. A piperazine ring will replace the propyl-diethylamine chain. The distal nitrogen of the piperazine will be substituted with a 2,3-dichlorophenyl group, a common motif in potent DRD2 antagonists known to occupy a specific subpocket within the receptor. This modification aims to optimize interactions with the receptor, reduce conformational flexibility, and enhance binding affinity.\",\n    \"Final_Target_Molecule\": \"COc1ccc2c(c1)COc1ncccc1C1N2CCN(c3ccc(Cl)c(Cl)c3)CC2\"\n  }\n]"
    },
    {
        "src_smiles": "COc1cc2c(cc1OC)C1CC(N)C(N3CCC(C)CC3=O)CN1CC2",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a dimethoxy-substituted tetrahydroisoquinoline core fused with a bridged piperidine ring system. Key functional groups include two methoxy ethers on the aromatic ring, a primary amine, and a complex N-substituted piperidone moiety attached to the carbon adjacent to the primary amine within the bridged system.\",\n    \"Property_Analysis\": \"The core structure resembles scaffolds found in some CNS-active compounds. The primary amine is a potential key pharmacophore for interaction with aminergic receptors like DRD2, likely forming a salt bridge with acidic residues (e.g., Asp114). The dimethoxy groups contribute to lipophilicity and potential hydrophobic interactions. The bridged system imparts rigidity, while the piperidone adds polarity and potential hydrogen bonding sites.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The primary amine, while potentially interacting, might not be optimally positioned or substituted for high-affinity DRD2 binding. The complex piperidone substituent adds significant bulk and polarity, which may not be favorable for the DRD2 binding pocket compared to N-arylalkyl substituents commonly found in potent DRD2 ligands. The overall conformation might not perfectly match the receptor's active site requirements.\",\n    \"Optimization_for_Source_Molecule\": \"Focus on modifying the primary amine, a common strategy for DRD2 ligand optimization. Replace the primary amine hydrogen with an N-phenethyl group (-(CH2)2Ph). This group is frequently found in potent DRD2 agonists/antagonists and is known to occupy a hydrophobic pocket within the receptor, potentially enhancing binding affinity. The core structure and the piperidone moiety are kept intact in this optimization step.\",\n    \"Final_Target_Molecule\": \"COc1cc2c(cc1OC)C1CC(NCCc3ccccc3)C(N3CCC(C)CC3=O)CN1CC2\"\n  }\n]"
    },
    {
        "src_smiles": "C=CCN1CCN(Cc2ccccc2)C(C(=O)Oc2c(OC)cccc2OC)C1",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a central piperazine ring. One nitrogen atom is substituted with an allyl group (C=CCN-), and the other nitrogen is substituted with a benzyl group (-N(Cc1ccccc1)). One of the piperazine ring carbons adjacent to the benzyl-substituted nitrogen is chiral and bears an ester functional group, specifically a 2,6-dimethoxybenzoate ester (-C(C(=O)Oc1c(OC)cccc1OC)).\",\n    \"Property_Analysis\": \"Piperazine scaffolds are common cores for Dopamine D2 Receptor (DRD2) ligands. The nature of the N-substituents and the group attached to the chiral carbon significantly influences DRD2 binding affinity, selectivity, and functional activity (agonist/antagonist). The N-allyl and N-benzyl groups, along with the ester moiety, contribute to the overall physicochemical properties and receptor interaction profile.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The N-allyl group is potentially metabolically labile (prone to oxidation/epoxidation) and may not provide optimal hydrophobic interactions within the DRD2 binding site compared to slightly longer alkyl chains like n-propyl, often found in potent DRD2 ligands. The 2,6-dimethoxybenzoate ester might not be the most suitable group for strong DRD2 binding; many potent DRD2 antagonists feature specific substituted benzamide moieties instead of benzoate esters, and the ester linkage itself is prone to hydrolysis by esterases.\",\n    \"Optimization_for_Source_Molecule\": \"To enhance DRD2 activity and improve metabolic stability: 1. Replace the N-allyl group with an N-propyl group (CCCN-), a common modification that often increases DRD2 affinity/selectivity. 2. Replace the 2,6-dimethoxybenzoate ester with a substituted benzamide known to interact favorably with DRD2. Convert the ester linkage (-C(=O)O-Ar) to an amide linkage (-C(=O)NH-Ar) and replace the 2,6-dimethoxyphenyl ring with a 5-chloro-2-methoxyphenyl ring, forming a 5-chloro-2-methoxybenzamide moiety, which is a common pharmacophore found in several DRD2 antagonists.\",\n    \"Final_Target_Molecule\": \"CCCN1CCN(Cc2ccccc2)C(C(=O)Nc1ccc(Cl)c(OC)c1)C1\"\n  }\n]"
    },
    {
        "src_smiles": "COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCNC(C)C",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule possesses a quinazoline core. Position 4 is substituted with a 3-chloro-4-fluoroanilino group. Position 6 has a methoxy group. Position 7 features a (2-(isopropylamino)ethoxy) side chain, containing a secondary amine.\",\n    \"Property_Analysis\": \"The molecule contains structural elements sometimes found in GPCR ligands, notably the basic secondary amine in the side chain separated from an aromatic system by a flexible linker (ethoxy). However, the 4-anilinoquinazoline core is more characteristic of kinase inhibitors (e.g., EGFR/HER2 inhibitors like Lapatinib). DRD2 activity often relies on specific pharmacophore patterns involving aromatic rings and basic amines, which are present but potentially suboptimally arranged.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The primary limitation is the quinazoline scaffold and 4-anilino substitution, strongly associated with kinase inhibition rather than potent DRD2 activity. The side chain's secondary isopropylamine, while basic, might not be the optimal basic moiety or fit sterically compared to motifs commonly found in potent DRD2 ligands (e.g., piperazines, specific piperidines). The overall structure may lead to off-target kinase activity and lack specific interactions crucial for high DRD2 affinity.\",\n    \"Optimization_for_Source_Molecule\": \"To improve DRD2 activity, focus on modifying the side chain at position 7, which contains the basic amine likely crucial for GPCR interaction. Replace the isopropylaminoethoxy group with a moiety more commonly associated with DRD2 ligands. A 2-(4-methylpiperazin-1-yl)ethoxy group is proposed. This introduces a piperazine ring, a privileged structure for DRD2 ligands, maintains the linker length, and provides a tertiary amine within the piperazine ring.\",\n    \"Final_Target_Molecule\": \"COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCN1CCN(C)CC1\"\n  }\n]"
    },
    {
        "src_smiles": "Cc1onc(-c2ccccc2)c1C(=O)N1CCN(c2ccc([N+](=O)[O-])cc2)CC1",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule consists of a central piperazine ring. One nitrogen of the piperazine is acylated with a 3-phenyl-5-methylisoxazole-4-carbonyl group. The other piperazine nitrogen is attached to a 4-nitrophenyl group.\",\n    \"Property_Analysis\": \"The molecule contains a substituted phenylpiperazine moiety, which is a common pharmacophore found in many CNS active compounds, including some DRD2 ligands. The basic nitrogen of the piperazine is crucial for interaction with the acidic residue (Asp) in the DRD2 binding pocket. The overall lipophilicity and shape are determined by the isoxazole-phenyl and nitrophenyl groups.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The terminal 4-nitrophenyl group is a potential liability. Nitroaromatics can be metabolically reduced to toxic anilines and may confer poor pharmacokinetic properties. While sometimes present in active compounds, it's often suboptimal for CNS drug candidates and specifically for optimizing DRD2 interactions compared to other substituents commonly found in potent ligands (e.g., halogens, methoxy groups).\",\n    \"Optimization_for_Source_Molecule\": \"To potentially improve DRD2 activity and reduce metabolic liability, replace the electron-withdrawing and potentially toxic nitro group on the terminal phenyl ring. Replacing it with a halogen, such as chlorine, in the para position is a common strategy in optimizing phenylpiperazine-based DRD2 ligands. This maintains electronic similarity to some extent but removes the nitro group's specific liabilities and introduces a substituent frequently found in potent DRD2 antagonists (e.g., Haloperidol metabolite analog).\",\n    \"Final_Target_Molecule\": \"Cc1onc(-c2ccccc2)c1C(=O)N1CCN(c2ccc(Cl)cc2)CC1\"\n  }\n]"
    },
    {
        "src_smiles": "COc1cc(N)c(Cl)cc1C(=O)OCCN1CCC(C(N)=O)CC1",
        "prop": "drd",
        "json_results": "[{\n  \"Structural_Analysis_of_Source_Molecule\": \"The source molecule contains a substituted benzamide core (methoxy, amino, chloro substituents) linked via an ester bond to an N-ethylpiperidine moiety, which is further substituted with a primary carboxamide group.\",\n  \"Property_Analysis\": \"The benzamide scaffold is a known pharmacophore for DRD2 antagonists (e.g., amisulpride). The piperidine nitrogen provides a basic center, often crucial for interacting with aspartate residues in GPCRs like DRD2. The overall structure contains elements potentially interacting with DRD2 binding sites.\",\n  \"Limitation_in_Source_Molecule_for_Property\": \"The primary limitation is the ester linker (C(=O)OCCN). Ester bonds are susceptible to hydrolysis by esterases in plasma and tissues, leading to metabolic instability and potentially short duration of action. This can significantly limit *in vivo* efficacy and bioavailability for a CNS target like DRD2.\",\n  \"Optimization_for_Source_Molecule\": \"To improve metabolic stability while retaining the core pharmacophore elements, replace the labile ester linker with a more stable amide linker. An amide is an isostere of an ester and maintains similar geometry and hydrogen bonding potential but is significantly less prone to hydrolysis.\",\n  \"Final_Target_Molecule\": \"COc1cc(N)c(Cl)cc1C(=O)NCCN1CCC(C(N)=O)CC1\"\n}]"
    },
    {
        "src_smiles": "O=c1cc(-c2ccccc2)oc2cc(OCCNC3CCCCC3)cc(O)c12",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule is a coumarin derivative containing a phenyl substituent at position 3, a hydroxyl group at position 7, and an N-cyclohexylaminoethoxy side chain attached at position 6 via an ether linkage. Key features include the planar coumarin core, an aromatic phenyl ring, a phenolic hydroxyl, an ether linkage, and a secondary amine attached to a flexible alkyl chain terminating in a bulky cyclohexyl group.\",\n    \"Property_Analysis\": \"DRD2 receptor activity often requires specific pharmacophoric elements, typically including an aromatic region, a basic amine center capable of protonation, and an appropriate spatial distance and orientation between these features. The basic nitrogen in the N-cyclohexylaminoethoxy side chain is the likely primary interaction point with the receptor's acidic residue(s).\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The existing N-cyclohexylaminoethoxy side chain may have limitations for optimal DRD2 binding. The linker length (ethoxy), the flexibility, and the steric bulk/nature of the terminal cyclohexyl group might not provide the ideal fit or interaction profile within the DRD2 binding pocket compared to commonly observed motifs in potent DRD2 ligands (e.g., piperazines, piperidines attached via longer alkyl linkers).\",\n    \"Optimization_for_Source_Molecule\": \"To potentially improve DRD2 activity, the N-cyclohexylaminoethoxy side chain at position 6 will be replaced. A common strategy in DRD2 ligand design involves incorporating a terminal piperazine or piperidine ring attached via a flexible alkyl chain (often 3-4 carbons). We will replace the 'OCCNC3CCCCC3' group with a 4-(4-methylpiperazin-1-yl)butoxy chain ('OCCCCN1CCN(C)CC1'). This introduces a well-established DRD2 pharmacophore element (methylpiperazine) connected by a longer, flexible butyl ether linker, potentially improving receptor fit and interaction.\",\n    \"Final_Target_Molecule\": \"O=c1cc(-c2ccccc2)oc2cc(OCCCCN3CCN(C)CC3)cc(O)c12\"\n  }\n]"
    },
    {
        "src_smiles": "COc1ccc(C(=O)NC(C)c2nccs2)cc1OC1CCN(C(C)C)CC1",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a central amide core linking a dimethoxy-substituted phenyl ring to an alpha-methyl thiazolylethylamine moiety. The second methoxy group on the phenyl ring is further substituted with an N-isopropylpiperidine via an ether linkage.\",\n    \"Property_Analysis\": \"DRD2 activity often relies on a pharmacophore consisting of an aromatic group, a basic nitrogen center, and a specific spatial arrangement. The N-isopropylpiperidine provides the basic nitrogen, and the dimethoxy phenyl group serves as one aromatic component. The thiazole ring is another aromatic/heteroaromatic feature. The overall structure's conformation and the distance between the basic amine and aromatic groups are crucial for receptor binding.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The combination of the amide linker, the specific alpha-methyl substitution, and the thiazole ring might not provide the optimal geometry or electronic interactions for high-affinity DRD2 binding. The ether-linked N-isopropylpiperidine attached to the second methoxy position might position the basic amine suboptimally relative to the primary aromatic core or introduce unfavorable steric/electronic interactions.\",\n    \"Optimization_for_Source_Molecule\": \"To potentially improve DRD2 binding, the thiazole ring, which might not be optimal for interaction within the DRD2 binding pocket, can be replaced with a simple phenyl ring. This modification maintains an aromatic character while altering the steric and electronic profile, potentially leading to a better fit and enhanced pi-stacking or hydrophobic interactions favored by DRD2 ligands.\",\n    \"Final_Target_Molecule\": \"COc1ccc(C(=O)NC(C)c2ccccc2)cc1OC1CCN(C(C)C)CC1\"\n  }\n]"
    },
    {
        "src_smiles": "Cc1c(-c2ccc(O)cc2)n(Cc2ccc(O)cc2)c2ccc(O)cc12",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a pyrrolo[2,1-a]isoquinoline core. Key substituents include a methyl group at position 3, a para-hydroxyphenyl group at position 1, and a para-hydroxybenzyl group attached to the nitrogen atom. An additional hydroxyl group is present on the isoquinoline portion of the core.\",\n    \"Property_Analysis\": \"Dopamine D2 Receptor (DRD2) ligands typically possess a basic nitrogen atom capable of forming ionic interactions with acidic residues (e.g., Asp114) in the receptor binding site, along with specific hydrophobic and aromatic features for optimal binding. The source molecule contains aromatic rings and polar hydroxyl groups, but lacks a readily protonatable basic amine.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The primary limitation is the absence of a basic amine group, which is a common pharmacophoric element crucial for high-affinity interaction with the DRD2 receptor. The nitrogen within the pyrroloisoquinoline core is part of an aromatic system and is not sufficiently basic. The existing hydroxyl groups might offer some hydrogen bonding but are unlikely to compensate for the lack of the key ionic interaction.\",\n    \"Optimization_for_Source_Molecule\": \"To enhance DRD2 activity, introduce a basic amine moiety. A strategic modification involves replacing the para-hydroxyl group on the N-benzyl substituent with an alkylamino chain, a common feature in DRD2 ligands. Specifically, replacing the hydroxyl with a 3-(dimethylamino)propyl group introduces a tertiary amine separated from the aromatic ring by a flexible three-carbon linker, which can adopt suitable conformations for receptor interaction and provides the necessary basicity.\",\n    \"Final_Target_Molecule\": \"CN(C)CCCc1ccc(CN2c3c(ccc(O)c3)c(C)c(-c3ccc(O)cc3)n2)cc1\"\n  }\n]"
    },
    {
        "src_smiles": "CN(C)c1cccc2c(S(=O)(=O)Nc3ccc(C#N)nn3)cccc12",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule, CN(C)c1cccc2c(S(=O)(=O)Nc3ccc(C#N)nn3)cccc12, features a dimethylamino group (-N(CH3)2) attached to a naphthalene core. This naphthalene system is substituted with a sulfonamide linker (-SO2NH-) which connects to a 3-cyano-1,2,5-thiadiazole heterocycle.\",\n    \"Property_Analysis\": \"DRD2 ligands often possess a basic amine center and aromatic/heteroaromatic moieties arranged in a specific spatial configuration. The dimethylamino group can serve as the basic center. The naphthalene and thiadiazole rings provide the aromatic/heteroaromatic character. The sulfonamide group acts as a linker and potential hydrogen bond donor/acceptor. The overall structure's conformation, lipophilicity, and electronic properties influence its potential interaction with the DRD2 binding site.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The rigid and bulky naphthalene core might sterically hinder optimal fitting into the DRD2 binding pocket. The relative positioning of the basic dimethylamino group and the sulfonamide-heterocycle moiety, dictated by the naphthalene scaffold, may not align ideally with the DRD2 pharmacophore requirements. The thiadiazole-cyano group might not be optimal for affinity or could introduce unfavorable interactions.\",\n    \"Optimization_for_Source_Molecule\": \"To improve potential DRD2 activity, the bulky naphthalene core is replaced with a simpler phenyl ring, which offers more conformational flexibility and is common in CNS agents. The dimethylamino group is positioned para to the sulfonamide linker to potentially mimic aspects of the dopamine pharmacophore (basic nitrogen relative to an aromatic ring). The complex thiadiazole-cyano heterocycle is replaced with a simpler 4-fluorophenyl group, a common substituent in DRD2 ligands that can participate in favorable interactions within the binding site.\",\n    \"Final_Target_Molecule\": \"CN(C)c1ccc(S(=O)(=O)Nc2ccc(F)cc2)cc1\"\n  }\n]"
    },
    {
        "src_smiles": "CN1CCN(CC(=O)N(C)c2ccc(Sc3ccccc3)cc2)CC1",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule consists of an N-methylpiperazine group connected via an N-methyl-N-phenylacetamide linker to a para-substituted diphenyl sulfide core.\",\n    \"Property_Analysis\": \"DRD2 ligands often possess a basic amine (like piperazine) linked by a chain of appropriate length (typically 3-4 atoms) to a lipophilic aromatic system. The source molecule has these general features, but the specific linker and aromatic core might not be optimal for potent DRD2 binding.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The acetamide linker (-C(=O)N(C)-) introduces rigidity, polarity (carbonyl), and specific length/conformational constraints that may not be ideal for the DRD2 binding pocket compared to simpler alkyl chains. The N-methyl group on the linker nitrogen adds steric bulk. The unsubstituted diphenyl sulfide core lacks specific features (like halogens or heterocycles) often found in potent DRD2 ligands to enhance binding affinity.\",\n    \"Optimization_for_Source_Molecule\": \"Replace the N-methyl-N-phenylacetamide linker with a more flexible and typically favorable three-carbon alkyl chain (-CH2CH2CH2-). Introduce a para-fluoro substituent on the distal phenyl ring of the diphenyl sulfide moiety, a common modification known to enhance affinity for DRD2 receptors by potentially interacting with specific residues or altering electronic properties.\",\n    \"Final_Target_Molecule\": \"CN1CCN(CCCc2ccc(Sc3ccc(F)cc3)cc2)CC1\"\n  }\n]"
    },
    {
        "src_smiles": "COC(=O)c1cn(Cc2ccc3c(-c4ccc(F)cc4)cc(C(N)=O)nc3c2)cn1",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a central quinoline-like core containing a primary amide and substituted with a 4-fluorophenyl group. This core is linked via a methylene bridge (-CH2-) attached to the phenyl ring portion of the fused system, connecting to a nitrogen atom of an imidazole ring. The imidazole ring is further substituted with a methyl ester group.\",\n    \"Property_Analysis\": \"DRD2 receptor ligands typically possess key pharmacophoric features, including a basic amine center (protonatable at physiological pH) for interaction with acidic residues like Asp114 in the binding site, along with aromatic/hydrophobic regions for pocket fitting. The source molecule contains aromatic systems (fluorophenyl, fused core, imidazole) and hydrogen bond acceptors/donors (amide, ester, nitrogens) but lacks a strongly basic amine.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The primary limitation for potent DRD2 activity is the absence of a readily protonatable basic amine group. The existing nitrogen atoms in the imidazole and fused core are relatively weak bases and are unlikely to form the canonical ionic interaction crucial for high-affinity DRD2 binding.\",\n    \"Optimization_for_Source_Molecule\": \"To improve DRD2 activity, the non-basic, metabolically potentially labile methyl ester-imidazole moiety will be replaced. A piperazine ring, a common motif in CNS agents and containing two basic nitrogens, will be introduced. It will be attached via one of its nitrogen atoms to the existing methylene linker, thereby incorporating the crucial basic amine feature while retaining the core structure.\",\n    \"Final_Target_Molecule\": \"O=C(N)c1cc(-c2ccc(F)cc2)c3nc(Cc4ccc(N5CCNCC5)cc4)ccc13\"\n  }\n]"
    },
    {
        "src_smiles": "COc1cccc(CNC(=O)c2nc3cccc(-c4ccccc4)c3c(=O)[nH]2)c1",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a methoxy-substituted benzyl group linked via a secondary amide bond (-NH-C(=O)-) to a complex, polycyclic, and relatively planar heterocyclic system. This heterocycle is a pyrido[3,2-g]quinoline-2,8-dione core, which includes a pyridine ring fused to a quinoline-dione structure, further substituted with a phenyl group.\",\n    \"Property_Analysis\": \"The molecule possesses multiple hydrogen bond acceptors (methoxy O, amide C=O, ketone C=O, pyridine N) and donors (amide NH, ring NH). It has several aromatic rings contributing to potential hydrophobic interactions. However, it lacks a readily protonatable basic amine, a common feature in high-affinity DRD2 ligands for interacting with Asp114.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The primary limitation for DRD2 activity is the absence of a sufficiently basic nitrogen atom. The amide nitrogen is non-basic due to resonance, and the nitrogen within the quinoline-dione ring system (NH) also exhibits low basicity. This prevents the key ionic interaction with the conserved aspartate residue in the DRD2 binding pocket.\",\n    \"Optimization_for_Source_Molecule\": \"To enhance DRD2 activity, a basic amine center needs to be introduced. A common strategy is to replace the existing amide linker with a piperazine linker. The methoxybenzyl moiety will be attached to one nitrogen of the piperazine, and the other nitrogen will be acylated and attached to the pyrido[3,2-g]quinoline-2,8-dione core, maintaining the connection point. This modification introduces a tertiary amine within the piperazine ring, providing the required basic center for interaction with Asp114, while preserving the general structure and other potential interaction points.\",\n    \"Final_Target_Molecule\": \"COc1cccc(CN2CCN(C(=O)c3nc4cccc(-c5ccccc5)c4c(=O)[nH]3)CC2)c1\"\n  }\n]"
    },
    {
        "src_smiles": "CNCc1cc(C(=O)N2CCCN(C3CC3)CC2)ccc1Oc1ccccc1C#N",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features an N-methylaminomethyl group attached to a central phenyl ring, which is linked via an amide bond to an N-cyclopropylpiperazine moiety. The central phenyl ring is also connected through an ether linkage to a terminal cyanophenyl group. Key features include two potential basic nitrogens (secondary amine and piperazine tertiary amine), an amide linker, flexible ether linkage, and aromatic systems.\",\n    \"Property_Analysis\": \"DRD2 ligands typically possess a basic nitrogen atom to interact with Asp114 in the receptor's transmembrane helix 3. Both the N-methylamino nitrogen and the piperazine nitrogen could potentially serve this role. Aromatic rings can engage in pi-stacking interactions within the binding pocket. The N-cyclopropylpiperazine is a common motif in CNS ligands, potentially influencing affinity and selectivity. The overall structure fits the general profile of a GPCR ligand.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The presence of two basic centers might lead to suboptimal binding or multiple binding modes, potentially reducing affinity. The N-methylaminomethyl group's flexibility might hinder optimal positioning. The flexible diphenyl ether linker and the bulky cyanophenyl group might not provide the ideal shape complementarity or specific interactions required for high affinity binding within the DRD2 pocket compared to more optimized scaffolds.\",\n    \"Optimization_for_Source_Molecule\": \"To enhance DRD2 affinity, simplify the distal portion of the molecule by removing the flexible ether linkage and the terminal cyanophenyl group. Replace this bulky, flexible moiety with a smaller, electronegative atom directly attached to the central phenyl ring, such as chlorine. This modification aims to reduce conformational flexibility, decrease molecular weight and potentially improve interactions within the receptor subpockets often occupied by halogens in known DRD2 ligands. Retain the N-methylaminomethyl group and the N-cyclopropylpiperazine amide structure as potential key binding elements.\",\n    \"Final_Target_Molecule\": \"CNCc1cc(C(=O)N2CCCN(C3CC3)CC2)ccc1Cl\"\n  }\n]"
    },
    {
        "src_smiles": "CCS(=O)(=O)N(C)C(C)c1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1",
        "prop": "drd",
        "json_results": "[{\n  \"Structural_Analysis_of_Source_Molecule\": \"The source molecule contains an ethylsulfonyl group attached to a chiral secondary amine nitrogen. This amine is further substituted with a methyl group and a pyridylethyl moiety. The pyridine ring is substituted at the 4-position with a 5,6,7,8-tetrahydro-[1,6]naphthyridine system. The nitrogen atom at the 6-position of the tetrahydro-[1,6]naphthyridine core is substituted with a carboxamide group.\",\n  \"Property_Analysis\": \"Dopamine D2 receptor ligands often feature a basic amine separated from an aromatic system by a linker. The tertiary amine N(C)C(C)c1... fulfills this requirement. The tetrahydro-[1,6]naphthyridine core is a privileged scaffold found in CNS active compounds and likely interacts with the receptor binding site. The sulfonamide and carboxamide groups influence polarity, solubility, and potential hydrogen bonding interactions, which modulate receptor affinity and selectivity.\",\n  \"Limitation_in_Source_Molecule_for_Property\": \"The carboxamide group on the tetrahydro-[1,6]naphthyridine nitrogen introduces polarity and hydrogen bonding capabilities. While potentially beneficial, this specific substituent might not be optimal for DRD2 binding affinity or selectivity compared to simpler alkyl groups or hydrogen, which are common in other DRD2 ligands targeting this region. It could introduce unfavorable steric or electronic interactions or reduce lipophilicity needed for BBB penetration.\",\n  \"Optimization_for_Source_Molecule\": \"To potentially improve DRD2 activity, the carboxamide group (-C(N)=O) on the tetrahydro-[1,6]naphthyridine nitrogen can be removed and replaced with a hydrogen atom. This simplification reduces polarity and potential steric hindrance at this position, potentially leading to a better fit within the DRD2 binding pocket, mimicking structures of known high-affinity ligands where this position is often unsubstituted or has small alkyl groups.\",\n  \"Final_Target_Molecule\": \"CCS(=O)(=O)N(C)C(C)c1cncc(-c2cnc3c(c2)CCCN3)c1\"\n}]"
    },
    {
        "src_smiles": "COc1cccc(C(O)c2nc(-c3cccc(C(F)(F)F)c3)c[nH]2)c1",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a central imidazole ring substituted at C2 with a 3-(trifluoromethyl)phenyl group and at C4 (or C5, assuming standard imidazole numbering) with a hydroxy(3-methoxyphenyl)methyl group. Key features include: two aromatic rings (one electron-rich with methoxy, one electron-poor with CF3), a secondary alcohol linker creating a chiral center, and an imidazole ring containing basic nitrogen atoms.\",\n    \"Property_Analysis\": \"DRD2 receptor activity often relies on specific pharmacophoric elements: a basic nitrogen atom capable of protonation (provided by the imidazole), aromatic rings for hydrophobic and pi-stacking interactions (provided by the two phenyl rings), and potentially hydrogen bond donors/acceptors (alcohol OH, imidazole NH). The distance and relative orientation of these features are critical for binding affinity and efficacy.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The secondary alcohol linker introduces flexibility and a chiral center. This flexibility might allow conformations unfavorable for optimal DRD2 binding, increasing the entropic penalty. The chirality means the molecule exists as enantiomers, which likely have different DRD2 activities; the racemate may have lower overall potency or efficacy. The alcohol group itself might not be optimally positioned for hydrogen bonding within the DRD2 active site compared to functional groups in known high-affinity ligands.\",\n    \"Optimization_for_Source_Molecule\": \"To address the flexibility and chirality of the alcohol linker, it can be replaced with a ketone (C=O). This removes the chiral center, introduces planarity to the linker, potentially improving conformational restriction, and changes the hydrogen bonding potential (removes donor, keeps acceptor). This modification maintains the core connection between the imidazole and the 3-methoxyphenyl ring while potentially improving binding properties and simplifying the molecule's stereochemical profile.\",\n    \"Final_Target_Molecule\": \"COc1cccc(C(=O)c2nc(-c3cccc(C(F)(F)F)c3)c[nH]2)c1\"\n  }\n]"
    },
    {
        "src_smiles": "COc1cc2c(cc1OC)C1CC(N)C(N3CC(C)CCC3=O)CN1CC2",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a complex polycyclic structure containing a 6,7-dimethoxy-tetrahydroisoquinoline core. Key functional groups include a primary amine (NH2) and a complex N-substituted piperidinone moiety attached to the alicyclic part of the tetrahydroisoquinoline system (specifically, N-(1-methyl-2-oxopiperidin-3-yl) group attached via its nitrogen to a carbon atom within the core ring structure adjacent to the primary amine). The dimethoxybenzene ring provides an aromatic component.\",\n    \"Property_Analysis\": \"DRD2 receptor ligands often possess an aromatic system and one or more basic nitrogen atoms separated by a specific distance, along with potential hydrogen bond acceptors/donors and lipophilic regions. The source molecule contains the aromatic dimethoxybenzene ring and two potential basic nitrogens (the primary amine and the tetrahydroisoquinoline nitrogen). The piperidinone group adds steric bulk and a carbonyl oxygen (H-bond acceptor).\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The large and conformationally specific N-substituted piperidinone group attached to the alicyclic ring (N3CC(C)CCC3=O) may introduce steric hindrance or unfavorable interactions within the DRD2 binding site. Its specific shape and electronic properties might not be optimal for high-affinity binding compared to substituents commonly found in potent DRD2 ligands. The relative positioning and complex substitution pattern on the alicyclic ring might lead to a suboptimal overall conformation for receptor engagement.\",\n    \"Optimization_for_Source_Molecule\": \"To potentially improve DRD2 activity, the complex and bulky N-substituted piperidinone group (N3CC(C)CCC3=O) is identified as a primary target for modification. Simplification is chosen as the strategy. This bulky group, attached to the carbon adjacent to the primary amine, will be replaced by a simple hydroxyl group (-OH). This modification reduces steric bulk, removes the potentially unfavorable piperidinone ring, and introduces a hydrogen bond donor/acceptor (hydroxyl) which might form favorable interactions within the DRD2 binding pocket, aiming for a potentially better fit and improved affinity.\",\n    \"Final_Target_Molecule\": \"COc1cc2c(cc1OC)C1CC(N)C(O)CN1CC2\"\n  }\n]"
    },
    {
        "src_smiles": "c1ccc(CNc2ccnc(NC3CCN(Cc4ccccc4)CC3)n2)cc1",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a central 2,4-diaminopyrimidine scaffold. The 4-amino position is substituted with an N-benzylpiperidine ring. The 2-amino position is substituted with a benzyl group via a methylene linker (-CH2-NH-). Key functional groups include two secondary amines linking the substituents to the pyrimidine, a tertiary amine within the piperidine ring, and two phenyl rings.\",\n    \"Property_Analysis\": \"DRD2 ligands typically require a basic amine center (provided here by the piperidine nitrogen) for interaction with key receptor residues (e.g., Asp114) and hydrophobic moieties to occupy binding pockets. The N-benzylpiperidine motif contributes both a basic center and hydrophobicity. The overall structure suggests potential interaction with the DRD2 receptor, but its affinity and selectivity profile are undetermined.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The molecule possesses significant flexibility due to multiple single bonds (two benzyl groups, linkers), which can lead to an entropic penalty upon binding. The specific N-benzyl substituent on the piperidine might not be optimal for high-affinity DRD2 binding compared to established pharmacophores (e.g., butyrophenone side chains). The symmetry and bulk of having two benzyl groups might lead to non-specific binding or suboptimal fit within the DRD2 active site. The aminopyrimidine core might not be the most favorable scaffold compared to known DRD2 ligand cores.\",\n    \"Optimization_for_Source_Molecule\": \"Optimization focuses on incorporating known DRD2 pharmacophoric features while reducing flexibility and potentially improving fit. The N-benzyl group on the piperidine is replaced with a 4-(4-fluorophenyl)-4-oxobutyl group, a classic butyrophenone side chain known to confer high DRD2 affinity (as seen in Haloperidol). This introduces favorable hydrophobic interactions and a ketone for potential hydrogen bonding. To reduce complexity and flexibility on the other side of the scaffold, the benzylamine group at the 2-position of the pyrimidine is replaced with a smaller, less conformationally demanding methylamino group.\",\n    \"Final_Target_Molecule\": \"CNC1=NC=NC(NC2CCN(CCCC(=O)C3=CC=C(F)C=C3)CC2)=C1\"\n  }\n]"
    },
    {
        "src_smiles": "COC(=O)C1C(c2ccc(C#CCCCCO)cc2)CC2CCC1N2C",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a tropane-like bicyclic amine core. Key substituents include a methyl ester group at C2 (likely beta), a phenyl ring at C3 (likely beta), and an N-methyl group. The phenyl ring is para-substituted with a hex-5-yn-1-yloxy group (-OCCCC#CH).\",\n    \"Property_Analysis\": \"DRD2 activity often requires a basic amine (present in the tropane core) for interaction with key receptor residues (e.g., Asp114) and an aromatic moiety for hydrophobic/pi-stacking interactions. The distance and relative orientation between these groups are crucial.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The long, flexible hex-5-yn-1-yloxy chain attached to the phenyl ring may not be optimal for DRD2 binding. Its flexibility can lead to an entropic penalty upon binding, and it might not fit well within the specific subpockets of the DRD2 binding site. The terminal alkyne and ether oxygen may not establish favorable interactions.\",\n    \"Optimization_for_Source_Molecule\": \"To potentially improve DRD2 binding affinity, the flexible and lengthy para-substituent on the phenyl ring will be replaced. A common strategy for enhancing DRD2 activity involves introducing smaller, electron-withdrawing groups or halogens at the para or meta positions of the phenyl ring, which can modulate electronic properties and improve hydrophobic interactions. Replacing the -OCCCC#CH group with a Chlorine atom (Cl) is a rational first step, as chloro-substituents are frequently found in potent DRD2 ligands.\",\n    \"Final_Target_Molecule\": \"COC(=O)C1C(c2ccc(Cl)cc2)CC2CCC1N2C\"\n  }\n]"
    },
    {
        "src_smiles": "OC(CN1C=COC=C1)c1cc(-c2ccc(F)cc2)nc2cc(F)ccc12",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a substituted quinoline core. Specifically, it's a 4-(4-fluorophenyl)-6-fluoroquinoline substituted at the 2-position with a (hydroxy(oxazol-2-yl)methyl) group. Key features include the quinoline nitrogen, two fluorine atoms providing lipophilicity and potential halogen bonding interactions, a hydroxyl group for hydrogen bonding, and an oxazole ring.\",\n    \"Property_Analysis\": \"DRD2 ligands often possess a core aromatic system and a basic nitrogen atom separated by an appropriate linker. The quinoline serves as the aromatic core. The hydroxyl group can form hydrogen bonds. The oxazole nitrogen is present but is part of an aromatic system and is weakly basic, which is generally suboptimal for strong interaction with key acidic residues (like Asp114) in the DRD2 binding site often targeted by basic amines.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The primary limitation for potent DRD2 activity is likely the lack of a sufficiently basic nitrogen atom positioned correctly relative to the quinoline core. The oxazole nitrogen is weakly basic. The overall size, shape, and electronic properties conferred by the oxazolylmethyl group might not be optimal for fitting into the DRD2 binding pocket and establishing key interactions required for high affinity.\",\n    \"Optimization_for_Source_Molecule\": \"Replace the oxazole ring with a group containing a more basic nitrogen, known to be favorable for DRD2 binding, such as a piperazine ring. Maintain the hydroxy-methylene linker structure but connect it to the piperazine nitrogen. The terminal nitrogen of the piperazine can be alkylated (e.g., with methyl) to potentially improve properties like CNS penetration or metabolic stability. This modification introduces a strongly basic nitrogen at a potentially favorable distance from the quinoline core, mimicking common DRD2 pharmacophores.\",\n    \"Final_Target_Molecule\": \"CN1CCN(CC(O)c2cc(-c3ccc(F)cc3)nc3cc(F)ccc23)CC1\"\n  }\n]"
    },
    {
        "src_smiles": "COc1ccccc1N1CCN(CCCCNC(=O)C2CC3CCCC3C2)CC1",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule consists of a methoxybenzene group attached to a piperazine ring. This piperazine acts as a linker, connected via a butyl chain to an amide functional group. The amide nitrogen is attached to the butyl chain, and the amide carbonyl is attached to a complex bicyclic hydrocarbon moiety (bicyclo[4.4.0]decane derivative).\",\n    \"Property_Analysis\": \"DRD2 receptor ligands typically require an aromatic moiety, a basic nitrogen atom (often tertiary amine like piperazine), and a linker of appropriate length connecting to another hydrophobic or hydrogen-bonding group. The source molecule possesses these general features: methoxybenzene (aromatic), piperazine (basic nitrogen), butyl chain + piperazine (linker), and the bicyclic amide group (hydrophobic/H-bonding tail).\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The methoxybenzene group might not be optimal for DRD2 binding compared to other aromatic systems frequently found in potent DRD2 ligands (e.g., halophenyl, benzisoxazole). The large, purely aliphatic bicyclic tail group (C2CC3CCCC3C2) lacks specific interactions (like halogen bonds or pi-stacking) often utilized for high affinity and may introduce excessive lipophilicity or steric hindrance within the DRD2 binding pocket. The length and flexibility of the butyl linker could also be suboptimal.\",\n    \"Optimization_for_Source_Molecule\": \"To potentially enhance DRD2 activity, we replace the methoxybenzene group with a chlorobenzene group, a common feature in DRD2 antagonists. We also replace the complex bicyclic tail group with a 2,3-dichlorophenyl group attached to the amide carbonyl. Dichlorophenyl groups are known pharmacophoric elements in potent DRD2 ligands (e.g., related to aripiprazole's structure). The core piperazine-butyl-amide linker structure is retained.\",\n    \"Final_Target_Molecule\": \"Clc1ccccc1N1CCN(CCCCNC(=O)c2ccc(Cl)c(Cl)c2)CC1\"\n  }\n]"
    },
    {
        "src_smiles": "CN1CCN(CCOc2cc(O)c3c(=O)cc(-c4ccccc4)oc3c2)CC1",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The molecule contains several key pharmacophoric features: 1) An N-methylpiperazine group, a common basic moiety in CNS ligands. 2) An ethoxy linker connecting the piperazine to the core. 3) A substituted coumarin (chromen-2-one) core. 4) A hydroxyl group on the coumarin ring capable of hydrogen bonding. 5) A phenyl substituent attached to the coumarin ring.\",\n    \"Property_Analysis\": \"The N-methylpiperazine group is expected to interact with the acidic residues (like Aspartate) in the DRD2 binding pocket via ionic or hydrogen bonding interactions, which is crucial for affinity. The coumarin core acts as a scaffold, positioning the substituents. The phenyl ring likely occupies a hydrophobic pocket. The overall structure suggests potential CNS activity due to the piperazine group, but specific DRD2 affinity and selectivity depend on the precise arrangement and nature of substituents.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The unsubstituted phenyl ring might lack specific interactions or optimal hydrophobic contacts within the DRD2 binding site. The substitution pattern on the coumarin ring and the linker length/flexibility might not be fully optimized for maximal DRD2 potency and selectivity. Lipophilicity and metabolic stability could also be limiting factors depending on the specific binding mode.\",\n    \"Optimization_for_Source_Molecule\": \"To potentially enhance DRD2 activity, modifications targeting the phenyl ring substituent are proposed. Introducing a substituent on the phenyl ring can modulate electronic properties and improve hydrophobic or specific interactions (like halogen bonding) within the receptor pocket. A common strategy for DRD2 ligands is halogenation. Adding a para-Chlorine atom to the phenyl ring is hypothesized to improve binding affinity by occupying a hydrophobic subpocket or engaging in halogen bonding, without drastically altering the overall structure.\",\n    \"Final_Target_Molecule\": \"CN1CCN(CCOc2cc(O)c3c(=O)cc(-c4ccc(Cl)cc4)oc3c2)CC1\"\n  }\n]"
    },
    {
        "src_smiles": "O=C(Nc1nc2ccccc2n1Cc1ccc(Cl)cc1)c1ccco1",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The molecule features a benzimidazole core. One nitrogen atom of the imidazole ring is substituted with a 4-chlorobenzyl group. The other nitrogen atom (exocyclic amine) is part of an amide linkage connecting to a furan-2-carbonyl group.\",\n    \"Property_Analysis\": \"The benzimidazole and furan rings offer potential aromatic interactions (pi-stacking) within the DRD2 binding site. The amide group can participate in hydrogen bonding. The chlorobenzyl group contributes to lipophilicity and may occupy a hydrophobic pocket, potentially interacting via halogen bonding.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"A significant limitation for potent DRD2 activity is the absence of a strongly basic amine group, which is typically required for interaction with the conserved aspartate residue (Asp114) in the transmembrane helix 3 (TM3) of the DRD2 receptor. The overall structure might not possess the optimal conformation or electrostatic profile for high-affinity binding.\",\n    \"Optimization_for_Source_Molecule\": \"To improve DRD2 activity, introduce a basic amine pharmacophore. A common strategy is to incorporate a piperidine or piperazine moiety connected via an appropriate linker. Here, the N-(4-chlorobenzyl) group on the benzimidazole is replaced with a 2-(piperidin-1-yl)ethyl group. This modification introduces a basic nitrogen atom at a distance often found in DRD2 ligands, potentially enabling the key interaction with Asp114.\",\n    \"Final_Target_Molecule\": \"O=C(Nc1nc2ccccc2n1CCN1CCCCC1)c1ccco1\"\n  }\n]"
    },
    {
        "src_smiles": "COc1ccc2[nH]cc(CCNC(=O)CI)c2c1",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule contains a 6-methoxyindole core linked via an ethylamine chain to a chloroacetamide group. Key features include the indole nitrogen, the ether oxygen, the amide linkage, and the reactive alpha-chloro carbonyl moiety.\",\n    \"Property_Analysis\": \"The indole scaffold is a common feature in some CNS-active compounds, including serotonin and dopamine receptor ligands. The ethylamine linker provides flexibility. The methoxy group influences electronics and lipophilicity. The terminal chloroacetamide is unusual for typical DRD2 ligands and introduces reactivity.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The primary limitation for potent DRD2 activity is the terminal chloroacetamide group. Known DRD2 ligands often possess a basic amine (frequently tertiary, incorporated into a piperidine or piperazine ring) linked by an appropriate spacer (often 3-5 atoms) to an aromatic system. The chloroacetamide lacks this basic amine crucial for interaction with key residues like Asp114 in the DRD2 binding site and is also a potentially toxic alkylating agent.\",\n    \"Optimization_for_Source_Molecule\": \"Replace the reactive and non-pharmacophoric chloroacetamide group (-C(=O)CI) with a moiety known to confer DRD2 affinity. A common strategy involves incorporating a substituted piperazine or piperidine ring containing a basic nitrogen. Specifically, replacing the -C(=O)CI with a 4-(2-methoxyphenyl)piperazine group, attached via the original amide nitrogen, introduces a well-established DRD2 pharmacophore element.\",\n    \"Final_Target_Molecule\": \"COc1ccc2[nH]cc(CCNC(=O)N3CCN(c4ccccc4OC)CC3)c2c1\"\n  }\n]"
    },
    {
        "src_smiles": "NS(=O)(=O)NCC1CCCc2cc(S(=O)(=O)c3cccc(F)c3)ccc21",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a primary sulfonamide (NS(=O)(=O)-) linked via an ethyl group (-CH2-) to a tetrahydroisoquinoline-like core (-C1CCCc2...). This core is substituted on its fused benzene ring with a diaryl sulfone moiety, specifically a (meta-fluorophenyl)sulfonyl group (-S(=O)(=O)c3cccc(F)c3).\",\n    \"Property_Analysis\": \"Dopamine D2 Receptor (DRD2) activity often requires specific pharmacophoric elements, typically including a basic nitrogen atom capable of protonation, an aromatic system, and a suitable linker connecting them, arranged in a specific spatial orientation to interact with the receptor binding site.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The primary sulfonamide nitrogen in the source molecule is non-basic due to the strong electron-withdrawing effect of the two sulfonyl oxygens. This lack of a basic center is a significant limitation, as DRD2 ligands usually require a protonatable amine for key interactions (e.g., salt bridge with Asp114 in the transmembrane helix 3). The overall structure deviates significantly from established DRD2 pharmacophores.\",\n    \"Optimization_for_Source_Molecule\": \"To improve DRD2 activity, the primary limitation (non-basic nitrogen) must be addressed. A key optimization step is to replace the primary sulfonamide group (NS(=O)(=O)-) with a functional group containing a basic nitrogen. Introducing a simple secondary amine, such as a methylamino group (CN-), provides the necessary basic center while maintaining a connection to the existing linker and core structure.\",\n    \"Final_Target_Molecule\": \"CNCC1CCCc2cc(S(=O)(=O)c3cccc(F)c3)ccc21\"\n  }\n]"
    },
    {
        "src_smiles": "O=C(CCN1CCN(CCOC(c2ccccc2)c2ccccc2)CC1)c1ccco1",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a central piperazine ring. One nitrogen is acylated with a furan-2-ylcarbonyl group via an ethylene linker (N-propionylfuran). The other piperazine nitrogen is substituted with a 2-(diphenylmethoxy)ethyl group.\",\n    \"Property_Analysis\": \"The molecule incorporates structural motifs potentially relevant for DRD2 activity. The piperazine core is a common scaffold in DRD2 ligands. The bulky diphenylmethoxyethyl group can interact with hydrophobic pockets in the receptor, similar to groups found in some antihistamines and antipsychotics which can have DRD2 affinity.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The furan-2-ylcarbonyl moiety is less commonly associated with high DRD2 affinity compared to other aromatic or heteroaromatic systems like substituted phenyl or benzamide groups. The furan ring might offer suboptimal interactions within the DRD2 binding site or could be metabolically labile. The specific substitution pattern and electronic nature of the furan may not be ideal for potent antagonism or agonism.\",\n    \"Optimization_for_Source_Molecule\": \"To potentially improve DRD2 binding, the furan-2-yl group can be replaced with an aromatic system known to enhance affinity, such as a 4-fluorophenyl group. This modification introduces a common pharmacophoric element found in potent DRD2 antagonists (e.g., the butyrophenone class) and aims to establish more favorable hydrophobic and electronic interactions within the receptor binding pocket.\",\n    \"Final_Target_Molecule\": \"O=C(CCN1CCN(CCOC(c2ccccc2)c2ccccc2)CC1)c1ccc(F)cc1\"\n  }\n]"
    },
    {
        "src_smiles": "CC(C)C1CC(=O)N(c2ccccc2C(=O)OCC2CCCN(CCCc3ccccc3)C2)C1=O",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The molecule contains an N-phenylpropylpiperidine moiety, which is a common pharmacophore for DRD2 ligands. This core is linked via an ester functional group at the piperidine C2 position to an N-phenyl glutarimide derivative. Key components include: 1) N-phenylpropylpiperidine, 2) Ester linkage, 3) N-(ortho-carboxyphenyl) substituent, 4) Glutarimide ring with an isopropyl group.\",\n    \"Property_Analysis\": \"The N-phenylpropylpiperidine core, particularly the basic nitrogen and the aromatic ring separated by a propyl chain, is expected to be the primary driver for DRD2 interaction, mimicking endogenous dopamine or known antagonists. The distance and conformation are crucial. The large N-phenyl-glutarimide-ester portion likely influences overall physicochemical properties (lipophilicity, size) and may occupy accessory binding pockets or hinder optimal binding of the core pharmacophore.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"1. Metabolic Instability: The ester linkage is susceptible to hydrolysis by esterases in vivo, leading to rapid metabolism, short duration of action, and potential formation of inactive metabolites. 2. Steric Hindrance/Suboptimal Conformation: The bulky N-(ortho-carboxy-phenyl)-glutarimide substituent attached via the ester may sterically clash with the receptor binding site or force the N-phenylpropylpiperidine pharmacophore into a non-ideal conformation for high-affinity binding. 3. Non-optimal Physicochemical Properties: The large size and specific polarity distribution imparted by the substituent might negatively affect membrane permeability or binding kinetics.\",\n    \"Optimization_for_Source_Molecule\": \"To improve DRD2 activity and metabolic stability, the primary optimization strategy focuses on replacing the metabolically labile ester linkage and the bulky, complex N-phenyl-glutarimide substituent while retaining the core N-phenylpropylpiperidine pharmacophore. The ester will be replaced with a more stable ether linkage (-O-). The large N-phenyl-glutarimide group will be replaced by a smaller, simpler aromatic group known to be favorable for CNS ligands, such as a para-fluorophenyl group. This reduces steric bulk, improves stability, and potentially enhances binding interactions.\",\n    \"Final_Target_Molecule\": \"Fc1ccc(OC2CCCN(CCCc3ccccc3)C2)cc1\"\n  }\n]"
    },
    {
        "src_smiles": "CN(C)S(=O)(=O)CCc1ccc(NC(=O)c2ncc(C#N)[nH]2)c(C2=CCCCC2)c1",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a central phenyl ring substituted with: 1) An ethyl-dimethylsulfonamide group [CN(C)S(=O)(=O)CC-]. 2) A cyclohexenyl group [C6H9-]. 3) An amide linker [-NHC(=O)-] connecting to a cyano-substituted pyrazole ring [-c2ncc(C#N)[nH]2]. Key functional groups include the sulfonamide, amide, pyrazole, cyano, and cyclohexenyl moieties.\",\n    \"Property_Analysis\": \"DRD2 receptor activity often relies on the presence of a basic amine (typically tertiary) capable of forming a salt bridge with Asp114 in the receptor binding site, along with specific aromatic interactions and overall molecular shape complementarity. The source molecule lacks a strongly basic amine; the pyrazole NH and amide nitrogen are weakly basic or neutral, and the sulfonamide nitrogen is non-basic.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The primary limitation for DRD2 activity is the absence of a sufficiently basic nitrogen atom required for the key ionic interaction with Asp114. The overall structure, particularly the sulfonamide and cyano-pyrazole combination, does not strongly resemble known potent DRD2 ligands, suggesting suboptimal fit and interactions within the DRD2 binding pocket.\",\n    \"Optimization_for_Source_Molecule\": \"Introduce a basic amine group, a key pharmacophoric feature for DRD2 ligands. Replace the cyano-pyrazole moiety attached to the amide carbonyl with a known DRD2-binding motif, such as an arylpiperazine group. Specifically, substitute the pyrazole ring [-c2ncc(C#N)[nH]2] with a 4-(4-fluorophenyl)piperazin-1-yl group [-N2CCN(c3ccc(F)cc3)CC2]. This incorporates a basic tertiary amine within the piperazine ring and an aromatic system (fluorophenyl) known to interact favorably with the DRD2 receptor.\",\n    \"Final_Target_Molecule\": \"CN(C)S(=O)(=O)CCc1ccc(NC(=O)N2CCN(c3ccc(F)cc3)CC2)c(C4=CCCCC4)c1\"\n  }\n]"
    },
    {
        "src_smiles": "CN(C)C1CCN(CCc2c(COc3ccccc3CO)sc3ccccc23)CC1",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule consists of an N,N-dimethyl-4-aminopiperidine moiety linked via an ethyl chain to a dibenzothiophene core. The dibenzothiophene is substituted with a bulky benzyloxy group bearing a terminal hydroxymethyl group.\",\n    \"Property_Analysis\": \"The molecule contains key pharmacophoric elements often found in DRD2 ligands: a basic amine (piperidine nitrogen) separated by a linker from an aromatic system (dibenzothiophene). The basic amine can form ionic interactions, while the aromatic core can engage in pi-stacking or hydrophobic interactions within the DRD2 binding site.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The large and flexible benzyloxy-(hydroxymethyl)phenyl substituent on the dibenzothiophene core may introduce significant steric bulk and unfavorable polar interactions, potentially hindering optimal fit and binding affinity within the relatively constrained DRD2 binding pocket.\",\n    \"Optimization_for_Source_Molecule\": \"To potentially improve DRD2 activity, the bulky and complex side chain (COc3ccccc3CO) can be simplified. Replacing it with a smaller, less sterically demanding group like a methoxy group (OC) could enhance binding by reducing steric clashes while maintaining some electronic influence on the aromatic core.\",\n    \"Final_Target_Molecule\": \"CN(C)C1CCN(CCc2c(OC)sc3ccccc23)CC1\"\n  }\n]"
    },
    {
        "src_smiles": "FC(F)(F)c1ccc(N2CCC(NC(c3ccc(Cl)cc3)c3cccnc3)CC2)nc1",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a trifluoromethylphenyl group attached to a pyrimidine ring. This pyrimidine is linked via a piperidine ring to an amide group. The amide connects to a chiral center bearing a 4-chlorophenyl group and a 3-pyridyl group.\",\n    \"Property_Analysis\": \"The core structure containing the piperidine, amide, and diphenylmethylamine-like motif (chlorophenyl/pyridyl) is characteristic of many CNS-active compounds, including ligands for dopamine receptors. The basic nitrogen in the piperidine and the aromatic groups are key for receptor interaction. The CF3 group significantly increases lipophilicity.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"While the core scaffold is relevant for DRD2 activity, the specific combination of the 3-pyridyl group and the trifluoromethylphenylpyrimidine 'tail' may not be optimal for high affinity or selectivity. The 3-pyridyl nitrogen's position and basicity might hinder optimal binding compared to a purely hydrophobic pocket interaction. High lipophilicity from CF3 might also lead to poor ADME properties or off-target effects.\",\n    \"Optimization_for_Source_Molecule\": \"To potentially improve DRD2 affinity and binding interactions, we can modify the diarylmethyl core and the tail region. Replace the 3-pyridyl group with a simple phenyl ring to enhance hydrophobic interactions common in DRD2 ligands. Simultaneously, replace the electron-withdrawing, lipophilic trifluoromethyl group on the pyrimidine-linked phenyl with a hydrogen atom to reduce lipophilicity and simplify the structure, potentially improving PK profile while assessing the core change's impact.\",\n    \"Final_Target_Molecule\": \"c1ccc(N2CCC(NC(c3ccc(Cl)cc3)c3ccccc3)CC2)nc1\"\n  }\n]"
    },
    {
        "src_smiles": "COc1ccc(N(C)CCCN2CCc3cc(OC)c(OC)cc3CC2=O)cc1OC",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a dimethoxyphenyl group attached to a tertiary amine (N-methyl, N-propyl). The propyl chain connects this amine to the nitrogen atom of a complex bicyclic lactam system (a dihydroisoquinolinone derivative) which itself contains a dimethoxy-substituted phenyl ring.\",\n    \"Property_Analysis\": \"The tertiary amine serves as a potential basic center crucial for interacting with acidic residues (like Asp114 in TM3) within the DRD2 binding pocket. The multiple aromatic rings (dimethoxyphenyl and the bicyclic system's phenyl part) can participate in hydrophobic and pi-stacking interactions with aromatic residues in the receptor (like Phe, Tyr, Trp). The overall structure suggests potential for DRD2 binding, but the specific arrangement and nature of the groups determine affinity and efficacy.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The bulky and relatively rigid bicyclic lactam moiety might cause steric hindrance or suboptimal positioning within the DRD2 binding site. The N-methyl group on the tertiary amine might not be optimal for binding compared to other substituents or a secondary amine. The specific arrangement and electronic properties of the dimethoxy groups on both phenyl rings may not maximize interactions or selectivity for DRD2.\",\n    \"Optimization_for_Source_Molecule\": \"To enhance DRD2 activity, the complex bicyclic lactam system is replaced with a simpler, known DRD2 pharmacophore element. A piperazine ring is introduced, linked via the propyl chain to the initial tertiary amine. The distal nitrogen of the piperazine is substituted with a 2,3-dichlorophenyl group, a motif found in potent DRD2 ligands like Aripiprazole, aiming to improve binding affinity through established interactions within the receptor pocket. The original dimethoxyphenyl-amine core structure is retained.\",\n    \"Final_Target_Molecule\": \"COc1ccc(N(C)CCCN2CCN(CC2)c3cccc(Cl)c3Cl)cc1OC\"\n  }\n]"
    },
    {
        "src_smiles": "CC(=O)N1CCc2ccc(C(=O)CCCN3CCN(Cc4ccccc4)CC3)cc2CC1",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule consists of three main fragments: an acetylated 1,2,3,4-tetrahydroisoquinoline (THIQ) core, a 4-oxobutyl linker attached to the phenyl ring of the THIQ, and an N-benzylpiperazine moiety attached to the terminus of the linker.\",\n    \"Property_Analysis\": \"The molecule possesses key features often associated with DRD2 ligands: a basic nitrogen atom within the piperazine ring capable of protonation and interaction with acidic residues (like Asp114) in the receptor binding site, and aromatic rings (phenyl group of THIQ and the benzyl group) which can engage in hydrophobic and pi-stacking interactions. The distance and orientation between the basic nitrogen and the aromatic centers, mediated by the linker, are critical for binding affinity.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The N-benzyl group on the piperazine might not be optimal for strong DRD2 binding. Many potent DRD2 antagonists/partial agonists feature substituted N-aryl or N-heteroarylpiperazine motifs, which often provide more favorable interactions within the receptor's binding pocket compared to a simple benzyl group. The flexibility of the linker might also allow non-optimal binding conformations.\",\n    \"Optimization_for_Source_Molecule\": \"To potentially enhance DRD2 activity, the N-benzyl group on the piperazine can be replaced with an N-aryl substituent known to confer high affinity in other DRD2 ligands. Specifically, replacing the benzyl group with a 2,3-dichlorophenyl group, a motif found in potent DRD2 modulators like Aripiprazole, could improve binding affinity through enhanced hydrophobic and specific interactions within the receptor site.\",\n    \"Final_Target_Molecule\": \"CC(=O)N1CCc2ccc(C(=O)CCCN3CCN(c4ccc(Cl)c(Cl)c4)CC3)cc2CC1\"\n  }\n]"
    },
    {
        "src_smiles": "Fc1cccc(CNc2cccc(-c3cc(NCCC4CCCNC4)ncc3Cl)n2)c1",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule, Fc1cccc(CNc2cccc(-c3cc(NCCC4CCCNC4)ncc3Cl)n2)c1, features a fluorobenzene ring linked via a benzylamine bridge to a pyridine ring. This pyridine is further substituted with a 3-chloro-5-(piperidinylethylamino)pyridine moiety. Key structural elements include aromatic rings (fluorobenzene, two pyridines), a flexible benzylamine linker, a basic piperidine nitrogen, and a halogen substituent (Chlorine).\",\n    \"Property_Analysis\": \"The molecule possesses features common in DRD2 ligands: a basic amine (piperidine nitrogen) capable of ionic interaction with receptor residues like Asp114, and multiple aromatic rings for potential pi-stacking interactions within the hydrophobic pockets of the DRD2 binding site. The overall distance and spatial arrangement between the basic amine and aromatic systems are critical for DRD2 activity.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The flexibility of the benzylamine and ethylamine linkers might lead to non-optimal binding conformations. The presence of the chlorine atom on the central pyridine ring could introduce steric hindrance, unfavorable electronic effects, or potential metabolic liabilities (e.g., toxicity, metabolic instability) impacting overall DRD2 suitability. The complexity of multiple linked heteroaromatic systems might also negatively affect pharmacokinetic properties.\",\n    \"Optimization_for_Source_Molecule\": \"To potentially improve DRD2 activity and drug-like properties, the chlorine atom on the central pyridine ring is replaced with a hydrogen atom. This modification aims to reduce potential steric clash, alter electronic properties potentially favorably, and mitigate risks associated with halogen metabolism, while preserving the core pharmacophore elements (basic amine, aromatic systems, linker lengths).\",\n    \"Final_Target_Molecule\": \"Fc1cccc(CNc2cccc(-c3cc(NCCC4CCCNC4)ncc3)n2)c1\"\n  }\n]"
    },
    {
        "src_smiles": "CC(=O)c1ccc(N2CCN(CC(O)(Cn3cncn3)c3ccc(F)cc3F)CC2)cc1",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The molecule consists of an N-(4-acetylphenyl)piperazine core. The second nitrogen of the piperazine is substituted with a 2-hydroxy-2-(2,4-difluorophenyl)-3-(1,2,4-triazol-1-yl)propyl group. Key features include: a basic piperazine nitrogen, an electron-withdrawing acetyl group on a phenyl ring, a chiral tertiary alcohol, a difluorophenyl group, and a 1,2,4-triazole heterocycle.\",\n    \"Property_Analysis\": \"The N-arylpiperazine motif is common in DRD2 ligands, where the basic piperazine nitrogen typically forms a salt bridge with Asp114 in the DRD2 binding site. The difluorophenyl group contributes to lipophilicity and potential aromatic/halogen bonding interactions. The hydroxyl group and triazole nitrogens can act as hydrogen bond donors/acceptors. The overall structure suggests potential interaction with the DRD2 receptor, but the specific substituents dictate affinity and efficacy.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The acetyl group on the phenyl ring might not be optimal for DRD2 binding compared to other substituents commonly found in potent ligands and could be a site for metabolism. The complex side chain, while containing potential interaction points (OH, triazole, difluorophenyl), might have suboptimal steric or electronic complementarity with the DRD2 binding pocket. The 1,2,4-triazole's specific electronic and H-bonding properties might not be ideal for maximizing affinity.\",\n    \"Optimization_for_Source_Molecule\": \"To enhance DRD2 activity, the acetyl group (CC(=O)) on the phenyl ring is replaced with a chloro (Cl) substituent, altering the electronic properties and potentially improving binding or metabolic stability. Additionally, the 1,2,4-triazole heterocycle (Cn1cncn1) in the side chain is replaced with an imidazole heterocycle (Cn1ccnc1) to explore different hydrogen bonding capabilities and electronic interactions within the receptor's accessory binding pocket.\",\n    \"Final_Target_Molecule\": \"Clc1ccc(N2CCN(CC(O)(Cn1ccnc1)c3ccc(F)cc3F)CC2)cc1\"\n  }\n]"
    },
    {
        "src_smiles": "COc1cc(N)c(Cl)cc1C(=O)OCCN1CCC(NC(=O)CC2CCCCC2)CC1",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule contains a substituted (2-amino-3-chloro-5-methoxy) benzoic acid core linked via an ester bond and an ethylene bridge to the nitrogen of a piperidine ring. The piperidine ring is further substituted at the 4-position with an amide linkage connecting to a cyclohexylacetyl group.\",\n    \"Property_Analysis\": \"DRD2 antagonists/ligands often possess a basic nitrogen (like the piperidine nitrogen) capable of interacting with Asp114 in the receptor binding site, and an aromatic moiety that engages in hydrophobic and aromatic interactions within the pocket. The overall molecular shape, linker length, and specific substituents significantly influence affinity and selectivity. The source molecule has these general features.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The ester linkage is a potential liability due to metabolic instability (hydrolysis by esterases), potentially leading to poor pharmacokinetic properties and short duration of action. The specific substitution pattern on the benzoic acid ring (amino, chloro, methoxy) may not be optimal for high-affinity DRD2 binding compared to established pharmacophores (e.g., benzamides like sulpiride/amisulpride). The free amino group could also be a site for metabolic modification or unwanted interactions.\",\n    \"Optimization_for_Source_Molecule\": \"To improve stability and potentially enhance DRD2 affinity, the labile ester linkage and ethylene bridge are replaced with a direct, more stable amide linkage between the aromatic core and the piperidine nitrogen. The original complex benzoic acid moiety is replaced with a 2-methoxy-5-sulfamoylbenzoyl group, incorporating features known to be favorable for DRD2 activity, drawing inspiration from potent benzamide antipsychotics like amisulpride. The cyclohexylacetyl amide side chain on the piperidine is retained.\",\n    \"Final_Target_Molecule\": \"COc1cc(S(=O)(=O)N)ccc1C(=O)N1CCC(NC(=O)CC2CCCCC2)CC1\"\n  }\n]"
    },
    {
        "src_smiles": "CC1CCCCN1CCC(CCN(C(C)C)C(C)C)(C(N)=O)c1ccccc1F",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a 2-methylpiperidine ring connected via an N-propyl linker to a quaternary carbon atom. This quaternary center is substituted with a fluorophenyl group, a carboxamide group, and a 2-(diisopropylamino)ethyl group.\",\n    \"Property_Analysis\": \"DRD2 receptor ligands typically possess a basic amine (like the piperidine nitrogen) capable of forming a salt bridge with Asp114, and an aromatic moiety interacting with hydrophobic/aromatic residues. The distance and geometry between these two features, modulated by the linker, are crucial for binding affinity.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The highly congested quaternary carbon center, bearing bulky substituents (fluorophenyl, carboxamide, diisopropylaminoethyl), likely introduces significant steric hindrance, preventing optimal binding within the DRD2 pocket. The polarity of the carboxamide and the large, flexible diisopropylaminoethyl side chain may also be detrimental to affinity or pharmacokinetic properties.\",\n    \"Optimization_for_Source_Molecule\": \"Simplify the structure by removing the complex quaternary center and its substituents. Replace the existing propyl linker and attached complex group with a linker and terminal group known to confer DRD2 activity. A common and effective motif is the butyrophenone pharmacophore. We will attach a 4-(4-fluorophenyl)-4-oxobutyl group to the nitrogen of the 2-methylpiperidine ring, retaining the basic amine and introducing a proven DRD2 binding element with an optimal linker length.\",\n    \"Final_Target_Molecule\": \"CC1CCCCN1CCCC(=O)c1ccc(F)cc1\"\n  }\n]"
    },
    {
        "src_smiles": "COC(=O)c1cccc(-c2cccc(OCC(O)CN3CCc4ccccc4C3)c2)c1",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule consists of a tetrahydroisoquinoline (THIQ) core, linked via a 2-hydroxy-1,3-propylamine linker to a meta-substituted phenoxy group. This phenoxy group is further part of a biphenyl system, where the distal phenyl ring bears a methyl ester group at the meta position.\",\n    \"Property_Analysis\": \"DRD2 receptor activity often involves a basic amine (provided by the THIQ nitrogen) for interaction with Asp114, aromatic groups (THIQ's fused benzene ring and the biphenyl system) for hydrophobic interactions, and hydrogen bond donors/acceptors (the hydroxyl group on the linker) for interactions with serine residues. The spatial arrangement and distance between these features are critical.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The methyl benzoate moiety adds polarity and bulk that may not be optimal for fitting into the typically hydrophobic DRD2 binding pocket. The biphenyl system introduces significant conformational flexibility, potentially hindering optimal alignment with receptor pharmacophore points. The overall complexity and specific substitution pattern (meta-meta biphenyl) might not be ideal compared to established DRD2 ligand scaffolds.\",\n    \"Optimization_for_Source_Molecule\": \"Simplify the molecule by removing the complex and potentially detrimental methyl benzoate-biphenyl system while retaining the core pharmacophoric elements. Replace the entire 'methoxycarbonyl-biphenyl-oxy' group attached to the propanolamine linker with a simpler aromatic group known to be tolerated or beneficial for DRD2 binding, such as a simple phenoxy group. This maintains the THIQ, the propanolamine linker (with its basic N and OH group), and an aromatic ether linkage, focusing on the core pharmacophore.\",\n    \"Final_Target_Molecule\": \"OC(COc1ccccc1)CN1CCc2ccccc2C1\"\n  }\n]"
    },
    {
        "src_smiles": "CS(=O)(=O)c1cccc(C(=O)NCc2cccc(-c3cccc(CN4CCNCC4)c3)c2)c1",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule, CS(=O)(=O)c1cccc(C(=O)NCc2cccc(-c3cccc(CN4CCNCC4)c3)c2)c1, features three phenyl rings. Ring A is meta-substituted with a methylsulfonyl group and an amide linker. The amide links Ring A to Ring B via a benzylamine connection (-C(=O)NHCH2-). Ring B is meta-substituted with the connection to the amide linker and a third phenyl ring (Ring C). Ring C is attached meta to Ring B and bears a meta-substituted benzylpiperazine group (-CH2-N4CCNCC4). The key pharmacophoric element is the basic piperazine nitrogen.\",\n    \"Property_Analysis\": \"The molecule possesses structural elements potentially conducive to DRD2 binding, including multiple aromatic rings for hydrophobic interactions and a terminal basic piperazine nitrogen, crucial for interacting with the conserved Asp114 residue in the DRD2 binding pocket. However, the overall architecture, particularly the linkers and substitution patterns, may not align perfectly with known high-affinity DRD2 ligand pharmacophores.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The primary limitations for DRD2 activity likely stem from the potentially suboptimal linker system and the indirect attachment of the piperazine. The -C(=O)NHCH2- amide linker imposes specific conformational constraints. More critically, the piperazine is attached via a methylene (-CH2-) bridge to Ring C (a benzylpiperazine), rather than directly as an N-arylpiperazine, which is a very common and often highly effective motif in DRD2 ligands. This indirect linkage might prevent the optimal positioning of the basic nitrogen relative to the aromatic systems for ideal receptor interaction.\",\n    \"Optimization_for_Source_Molecule\": \"To improve DRD2 activity, the optimization focuses on modifying the attachment of the crucial piperazine moiety to better resemble known DRD2 pharmacophores. Specifically, the methylene linker between Ring C and the piperazine nitrogen is removed. This converts the benzylpiperazine group (-CH2-N4CCNCC4) into a direct N-arylpiperazine group (-N4CCNCC4) attached to Ring C. This modification aims to improve the geometry and interaction of the basic nitrogen and the associated aromatic rings within the DRD2 binding site, particularly with Asp114, while retaining the rest of the molecular scaffold.\",\n    \"Final_Target_Molecule\": \"CS(=O)(=O)c1cccc(C(=O)NCc2cccc(-c3cccc(N4CCNCC4)c3)c2)c1\"\n  }\n]"
    },
    {
        "src_smiles": "COc1cc(N)c(Cl)cc1C(=O)NC1CCN(CC2CCN(C(=S)C(C)C)CC2)CC1OC",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule is a substituted benzamide derivative. It features a 2-methoxy-4-amino-5-chloro benzamide core attached via an amide linker to a piperidine ring. This piperidine ring contains an ether substituent (-OC) and is N-linked via a methylene bridge (-CH2-) to a second piperidine ring. The second piperidine ring is functionalized with an N-isopropylthiocarboxamide group.\",\n    \"Property_Analysis\": \"The benzamide scaffold is a common feature in many DRD2 antagonists (e.g., amisulpride, sulpiride). The basic nitrogen atoms within the piperidine rings are likely crucial for interaction with the acidic Asp114 residue in the DRD2 binding pocket. The overall structure suggests potential interaction with DRD2, but the specific substituents and the terminal group will significantly influence affinity and selectivity.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The primary limitation is likely the terminal N-isopropylthiocarboxamide group (N(C(=S)C(C)C)). This group is atypical for potent DRD2 ligands, which often feature aromatic or heteroaromatic moieties, or specific alkyl chains, capable of engaging hydrophobic or pi-stacking interactions in the distal binding pocket. The thioamide functionality and the bulky, non-aromatic isopropyl group may not provide optimal interactions for high DRD2 affinity. Additionally, the ether group on the first piperidine ring might introduce suboptimal polarity or steric interactions.\",\n    \"Optimization_for_Source_Molecule\": \"To enhance DRD2 activity, the terminal isopropylthiocarboxamide group should be replaced with a moiety known to favor DRD2 binding. A common optimization strategy involves introducing an aromatic group, such as a benzyl group, known to occupy the distal pocket effectively in many DRD2 ligands. Replacing C(=S)C(C)C with a benzyl group (Cc1ccccc1) introduces favorable hydrophobic and potential pi-stacking interactions.\",\n    \"Final_Target_Molecule\": \"COc1cc(N)c(Cl)cc1C(=O)NC1CCN(CC2CCN(Cc3ccccc3)CC2)CC1OC\"\n  }\n]"
    },
    {
        "src_smiles": "COc1cc2nc(N(C)CC3CCCCC3)nc(NC3CCN(C)CC3)c2cc1OC",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a 6,7-dimethoxyquinoxaline core. It is substituted at the C2 position with an N-methyl-N-(cyclohexylmethyl)amino group and at the C3 position with a 4-(N-methylpiperazin-1-yl)amino group.\",\n    \"Property_Analysis\": \"The molecule contains two basic nitrogen atoms (one tertiary amine in the C2 substituent, one tertiary amine in the C3 piperazine ring) which are often crucial for interaction with aminergic GPCRs like DRD2. The quinoxaline core provides an aromatic system. The overall structure possesses features potentially compatible with DRD2 binding, particularly the basic amine linked to an aromatic system.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The N-methyl-N-(cyclohexylmethyl)amino group at C2 is relatively bulky and flexible. This specific group might not adopt an optimal conformation for binding within the DRD2 active site, potentially leading to suboptimal affinity or potency. Its contribution compared to the more common arylpiperazine or related motifs found in DRD2 ligands is uncertain.\",\n    \"Optimization_for_Source_Molecule\": \"To potentially improve DRD2 interaction, the bulky and flexible N-methyl-N-(cyclohexylmethyl)amino group at the C2 position will be replaced. A less sterically demanding and potentially more favorable group for GPCR binding, such as a morpholino group, will be introduced. This maintains a heterocyclic amine but alters the steric and electronic profile at C2, aiming for a better fit in the DRD2 binding pocket while retaining the key C3 pharmacophore.\",\n    \"Final_Target_Molecule\": \"COc1cc2nc(N3CCOCC3)nc(NC4CCN(C)CC4)c2cc1OC\"\n  }\n]"
    },
    {
        "src_smiles": "CCS(=O)(=O)NC1CCC(Nc2cc(-c3cccc(NCc4cccc(F)c4)n3)c(Cl)cn2)CC1",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features an ethylsulfonylurea group attached to an aminocyclohexane linker. This aminocyclohexane is N-substituted to a 2-amino-4-chloro-5-arylpyrimidine core. The aryl substituent at the 5-position is a pyridine ring, which is further substituted at its meta-position with a (4-fluorobenzyl)aminomethyl group.\",\n    \"Property_Analysis\": \"The molecule possesses structural elements potentially relevant to GPCR binding, including multiple aromatic/heteroaromatic rings (pyrimidine, pyridine, fluorophenyl) capable of pi-stacking and hydrophobic interactions, and several nitrogen atoms (amine, pyrimidine, pyridine) acting as potential hydrogen bond acceptors or basic centers. The sulfonylurea group adds polarity and H-bonding capacity. DRD2 ligands often contain basic amine centers and aromatic features, suggesting parts of this molecule might interact with the receptor, although the overall combination is not a classic DRD2 pharmacophore.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The ethylsulfonylurea-aminocyclohexane moiety is not typical for high-affinity DRD2 ligands. The sulfonylurea group might introduce unfavorable steric or electronic properties for the DRD2 binding site. The cyclohexane linker provides flexibility but might not position the core optimally compared to more constrained linkers like piperidine or piperazine often found in DRD2 modulators. The overall lipophilicity and complex structure might also affect binding affinity and selectivity.\",\n    \"Optimization_for_Source_Molecule\": \"Replace the ethylsulfonylurea-aminocyclohexane part with a 4-arylpiperazine moiety, a common feature in DRD2 ligands known to interact favorably with the receptor. Specifically, replace `CCS(=O)(=O)NC1CCC(N-)CC1` with a 4-phenylpiperazin-1-yl group (`c1ccccc1N1CCN(-)CC1`). This modification introduces a well-established DRD2 pharmacophoric element while retaining the core heteroaromatic system presumed to be important for binding.\",\n    \"Final_Target_Molecule\": \"Clc1cncc(N2CCN(c3ccccc3)CC2)c1-c1cccc(NCc2cccc(F)c2)n1\"\n  }\n]"
    },
    {
        "src_smiles": "CC(C)c1ccccc1OCCN1CCC(N(CC2CC2)S(=O)(=O)c2cnn(C)c2)CC1",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The molecule features a para-isopropylphenyl group connected via an ether linkage and an ethyl spacer to the nitrogen atom of a piperidine ring. The piperidine ring is substituted at the C4 position with a secondary amine bearing a cyclopropylmethyl group and an N-methyl-pyrazole-sulfonyl group.\",\n    \"Property_Analysis\": \"The core structure, comprising the basic piperidine nitrogen, the ethyl linker, and the aromatic isopropylphenyl ether, represents a potential pharmacophore for Dopamine D2 Receptor (DRD2) binding, common in many CNS ligands. The complex substituent at the C4 position significantly influences the molecule's interaction profile, lipophilicity, and overall affinity.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The N(Cyclopropylmethyl)(N-methyl-pyrazole-sulfonyl) group at the C4 position is sterically demanding and electronically complex due to the sulfonamide moiety. This specific combination might not be optimal for high-affinity binding to the DRD2 receptor, potentially causing steric clashes or unfavorable electronic interactions within the binding site, and could negatively impact pharmacokinetic properties.\",\n    \"Optimization_for_Source_Molecule\": \"To potentially enhance DRD2 activity, the complex C4 substituent was replaced. The optimization involves substituting the N(Cyclopropylmethyl)(N-methyl-pyrazole-sulfonyl) group with a 4-fluorobenzoyl moiety. This introduces a ketone group, capable of acting as a hydrogen bond acceptor, and a 4-fluorophenyl ring, often associated with improved affinity in DRD2 ligands through favorable interactions within the binding pocket, while simplifying the overall structure at C4.\",\n    \"Final_Target_Molecule\": \"CC(C)c1ccccc1OCCN1CCC(C(=O)c2ccc(F)cc2)CC1\"\n  }\n]"
    },
    {
        "src_smiles": "CCc1cc(OC)cc2nc(-c3cccnc3N3CCC(C(=O)O)CC3)oc(=O)c12",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a substituted benzoxazinone core fused with an oxazole ring. The oxazole is linked to a pyridine ring, which is further substituted with an N-piperidine carboxylic acid moiety (assuming N3 represents the piperidine nitrogen attached to the pyridine ring, i.e., -c(pyridine)-N(piperidine)). Key groups include the ethyl and methoxy substituents on the benzoxazinone, the central heterocyclic systems, the basic piperidine nitrogen, and the acidic carboxylic acid group.\",\n    \"Property_Analysis\": \"Dopamine D2 Receptor (DRD2) activity often relies on the presence of a basic nitrogen atom (piperidine N) capable of protonation and interaction with acidic residues (like Asp) in the receptor binding site, along with appropriate aromatic/hydrophobic interactions mediated by the benzoxazinone and pyridine rings. The distance and orientation between the basic nitrogen and the aromatic systems are crucial for binding affinity.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The carboxylic acid group (-COOH) introduces significant polarity and a potential negative charge at physiological pH. This can be detrimental to DRD2 binding affinity as the binding site often favors basic or neutral ligands. Furthermore, the high polarity might limit Blood-Brain Barrier (BBB) penetration if CNS activity is desired, and carboxylic acids can be metabolic liabilities or cause pharmacokinetic issues.\",\n    \"Optimization_for_Source_Molecule\": \"To potentially improve DRD2 activity and pharmacokinetic properties, the carboxylic acid group will be replaced by its corresponding primary amide (-CONH2). This modification removes the acidic proton and negative charge while retaining hydrogen bonding capabilities (potential H-bond donor/acceptor). Amides generally have lower polarity than carboxylic acids, which might improve membrane permeability and alter binding interactions favorably for DRD2.\",\n    \"Final_Target_Molecule\": \"CCc1cc(OC)cc2nc(-c3cccnc3N3CCC(C(=O)N)CC3)oc(=O)c12\"\n  }\n]"
    },
    {
        "src_smiles": "O=C(NCCCN1CCOCC1)c1ccc2c(=O)n(Cc3ccc(Cl)cc3)c(=O)[nH]c2c1",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a phthalimide core N-substituted with a 4-chlorobenzyl group. This core is fused to a phenyl ring, which is substituted with an amide linker (-C(=O)NH-). The amide is connected via a propyl chain (-CH2CH2CH2-) to a morpholine ring.\",\n    \"Property_Analysis\": \"DRD2 ligands often contain an aromatic moiety, a basic nitrogen center, and a linker of specific length. The source molecule possesses these general features: the substituted phthalimide system acts as the aromatic part, the morpholine nitrogen provides the basic center, and the propylamide chain serves as the linker. The 4-chlorobenzyl group is also seen in some CNS-active compounds.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The morpholine ring, while containing a basic nitrogen, might be suboptimal for strong DRD2 interaction compared to more commonly employed basic moieties like piperazine or piperidine found in potent DRD2 antagonists (e.g., haloperidol family). The overall rigidity and electronic distribution of the phthalimide core might also limit optimal binding pocket complementarity.\",\n    \"Optimization_for_Source_Molecule\": \"To potentially enhance DRD2 affinity, the terminal basic amine will be modified. Replace the morpholine ring with a 4-substituted piperazine moiety, specifically 4-(4-fluorophenyl)piperazine. This modification introduces a structural element common in potent DRD2 antagonists (e.g., butyrophenones) while retaining the established linker length and the substituted phthalimide fragment.\",\n    \"Final_Target_Molecule\": \"O=C(NCCCN1CCN(c2ccc(F)cc2)CC1)c1ccc2c(=O)n(Cc3ccc(Cl)cc3)c(=O)[nH]c2c1\"\n  }\n]"
    },
    {
        "src_smiles": "CN(CC(F)(F)F)C(=O)c1ccc2cc(Oc3ccc(C(F)(F)F)cn3)ccc2n1",
        "prop": "drd",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a quinoline core substituted at position 6 with an N-methyl-N-(2,2,2-trifluoroethyl)carboxamide group and at position 7 with a [4-(trifluoromethyl)pyridin-2-yl]oxy group. Key structural elements include the quinoline ring system, an amide linker, electron-withdrawing trifluoroethyl and trifluoromethyl groups, an ether linkage, and a pyridine ring.\",\n    \"Property_Analysis\": \"The molecule possesses features potentially relevant to DRD2 activity, including aromatic rings (quinoline, pyridine) for hydrophobic/pi-stacking interactions and heteroatoms (N, O). The pyridine nitrogen atom provides a basic center, which is often crucial for interaction with the conserved aspartate residue in the DRD2 binding site. The trifluoromethyl group can enhance binding affinity and metabolic stability. The overall lipophilicity and electronic distribution are influenced by the fluorine substituents and heteroatoms.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The N-methyl-N-(2,2,2-trifluoroethyl)amide group at position 6 might present limitations. The amide nitrogen is non-basic, and the trifluoroethyl group could introduce steric hindrance or unfavorable electronic properties for optimal DRD2 binding compared to smaller alkyl or cycloalkyl groups often found in potent ligands. Furthermore, the positioning and basicity of the key interaction points (pyridine nitrogen, aromatic systems) relative to each other, dictated by the quinoline scaffold and linkers, may not be optimal for the DRD2 receptor conformation.\",\n    \"Optimization_for_Source_Molecule\": \"To potentially improve DRD2 activity, the N-methyl-N-(2,2,2-trifluoroethyl)amide substituent will be replaced. A common strategy for enhancing DRD2 activity involves incorporating a basic amine, often within a piperazine ring, which can interact favorably with the receptor's aspartate residue. Replacing the complex amide substituent with a piperazin-1-yl group attached to the carbonyl introduces a readily accessible basic nitrogen while retaining the core quinoline-ether-pyridine scaffold.\",\n    \"Final_Target_Molecule\": \"O=C(N1CCNCC1)c1ccc2cc(Oc3ccc(C(F)(F)F)cn3)ccc2n1\"\n  }\n]"
    }
]